JP4499406B2 - Intestinal function improving agent - Google Patents

Intestinal function improving agent Download PDF

Info

Publication number
JP4499406B2
JP4499406B2 JP2003423575A JP2003423575A JP4499406B2 JP 4499406 B2 JP4499406 B2 JP 4499406B2 JP 2003423575 A JP2003423575 A JP 2003423575A JP 2003423575 A JP2003423575 A JP 2003423575A JP 4499406 B2 JP4499406 B2 JP 4499406B2
Authority
JP
Japan
Prior art keywords
tea
intestinal function
molecular weight
polysaccharide
production example
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003423575A
Other languages
Japanese (ja)
Other versions
JP2005179279A (en
Inventor
清香 石川
文雄 南条
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Norin Co Ltd
Original Assignee
Mitsui Norin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Norin Co Ltd filed Critical Mitsui Norin Co Ltd
Priority to JP2003423575A priority Critical patent/JP4499406B2/en
Publication of JP2005179279A publication Critical patent/JP2005179279A/en
Application granted granted Critical
Publication of JP4499406B2 publication Critical patent/JP4499406B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Tea And Coffee (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

本発明は、茶の水乃至熱水抽出工程を経て得られる多糖類を有効成分とする腸内機能改善剤およびこの腸内機能改善剤を有効量配合してなる口腔適用対象物に関する。   The present invention relates to an intestinal function improving agent containing as an active ingredient a polysaccharide obtained through tea water or a hot water extraction step, and an oral application target comprising an effective amount of this intestinal function improving agent.

オリゴ糖や食物繊維などの難消化性糖質は、人の消化酵素では分解されないため、小腸までの器官による消化吸収を免れ、大腸まで達する。そして大腸へ達した難消化性糖質の一部は、腸内細菌により資化されて酢酸、プロピオン酸、酪酸などの短鎖脂肪酸、腸ガス、ビタミンなどを産生する。短鎖脂肪酸が腸内で増えると、腸内のpHが低下し、この作用により、ウェルシュ菌などの悪玉菌の増殖を抑制し、悪玉菌の作り出す腐敗産物や細菌毒素の生成を抑え、整腸作用をもたらすことが報告されている。また、この短鎖脂肪酸は、腸へ刺激を与え、ぜん動運動を活発にし、排便を促すことも知られている。従って、短鎖脂肪酸は、腸内環境を改善したり腸内代謝を改善したりすることで腸内機能を改善することから、腸内の短鎖脂肪酸を増加させて腸内機能改善作用をもたらす難消化性糖質は、古くからその有用性について着目されている(下記の非特許文献1および2を参照)。
このような特性を有する難消化性糖質は、既に、各種の飲食品や医薬品などに配合されて利用されている。例えば、オリゴ糖は、腸内でのビフィズス菌増殖促進作用、整腸作用、難う蝕性、ミネラル吸収促進効果など優れた生理作用を有することから、食品分野における機能性甘味料の一つとして注目されている。また、例えば、可溶性食物繊維およびガラクトオリゴ糖を併用することにより、腸内環境を改善し、腐敗産物を低下減少させ、肝性脳症、大腸癌の治療・予防となる食品や医薬品としての利用を考えた腸内環境改善用組成物が知られている(下記の特許文献1を参照)。また、フラクトオリゴ糖には、腸内のビフィズス菌を増殖させる作用があることが知られており(下記の特許文献2を参照)、例えば、セルロースとフラクトオリゴ糖からなる便秘改善、便通促進、便性改善用組成物(下記の特許文献3を参照)は、腎不全による透析患者の便通改善を目的としている。また、キクイモ、チコリ、ゴボウ、ダリアなどのキク科、ユリ科、アヤメ科、ラン科などの植物の根、根茎から得られる、フラクトース分子がβ−2,1結合で直鎖状に連なったイヌリンは、腸内細菌の調製や活性を高めて整腸作用および腸内清浄化を高める作用があることが知られている(下記の特許文献4を参照)。
一方、茶は様々な優れた薬理作用を持つことから注目を浴びており、例えば、その成分の代表格である茶カテキンには、腸内のpH、すなわち、糞便のpHを低下させることにより腸内の環境を改善する作用があることが知られている(下記の特許文献5を参照)。また、茶に含まれるカテキン以外の有効成分としては、分子量が約4万であって、L−アラビノース、D−リボース、D−グルコースを主要構成糖とする茶由来の多糖類が血糖降下作用を有することが知られており、この多糖類を有効成分とする血糖降下剤、糖尿病予防薬および健康食品が提案されている(下記の特許文献6を参照)。さらに、この多糖類を有効成分とする抗高脂血症用剤が提案されている(下記の特許文献7を参照)。また、茶葉を水乃至温水で抽出して得られる多糖類、とりわけ、分子量が約2万〜約20万の多糖類を有効成分とする血漿コレステロール降下剤が提案されている(下記の特許文献8を参照)。
しかしながら、茶の成分が有する作用の解明は未だ十分には行われておらず、未知な部分も多い。従って、腸内機能改善作用を有する茶の成分の探求は非常に意義深いものである。
特開平3−151854号公報 特開昭58−201980号公報 特開平1−319421号公報 特開2003−61592号公報 特開平6−166618号公報 特開昭63−308001号公報 特開平2−286620号公報 特開平6−80580号公報 原 健次 著、生理活性脂質‐短鎖脂肪酸の生化学と応用、幸書房、2000年12月 印南 敏 著、外16名、改定新版 食物繊維、第一出版株式会社、1995年5月
Indigestible carbohydrates, such as oligosaccharides and dietary fiber, are not degraded by human digestive enzymes, and thus escape digestive absorption by organs up to the small intestine and reach the large intestine. Some of the indigestible carbohydrates that reach the large intestine are assimilated by intestinal bacteria to produce short chain fatty acids such as acetic acid, propionic acid, and butyric acid, intestinal gas, and vitamins. When short-chain fatty acids increase in the intestine, the pH in the intestine decreases, and this action suppresses the growth of bad bacteria such as Clostridium perfringens and suppresses the production of spoilage products and bacterial toxins produced by the bad bacteria. It has been reported to produce an effect. This short-chain fatty acid is also known to stimulate the intestine, activate peristaltic movement, and promote defecation. Therefore, short-chain fatty acids improve the intestinal function by improving the intestinal environment and improving intestinal metabolism, so increasing the short-chain fatty acids in the intestine brings about an intestinal function improving action. Indigestible carbohydrates have been attracting attention for a long time (see Non-Patent Documents 1 and 2 below).
Indigestible carbohydrates having such characteristics have already been used in various foods and beverages and pharmaceuticals. For example, oligosaccharides have excellent physiological functions such as bifidobacteria growth promoting action in the intestine, intestinal regulating action, hard caries resistance, and mineral absorption promoting effect, and thus are attracting attention as one of functional sweeteners in the food field. Has been. In addition, for example, the combination of soluble dietary fiber and galactooligosaccharide improves the intestinal environment, lowers and reduces spoilage products, and is considered to be used as a food and medicine for the treatment and prevention of hepatic encephalopathy and colorectal cancer. A composition for improving the intestinal environment is known (see Patent Document 1 below). In addition, it is known that fructooligosaccharides have an action of proliferating intestinal bifidobacteria (see Patent Document 2 below). For example, constipation improvement consisting of cellulose and fructooligosaccharides, promotion of bowel movements, feasibility The composition for improvement (see Patent Document 3 below) aims to improve the bowel movement of dialysis patients due to renal failure. Inulin with fructose molecules linearly linked by β-2,1 bonds obtained from the roots and rhizomes of plants such as Jerusalem artichoke, chicory, burdock, and dahlia Is known to have an action to enhance the preparation and activity of intestinal bacteria and enhance the intestinal regulating action and intestinal cleansing (see Patent Document 4 below).
On the other hand, tea has been attracting attention because it has various excellent pharmacological actions. For example, tea catechin, which is a representative of its components, has been intestinalized by lowering the pH in the intestine, that is, the pH of feces. It is known that there is an effect of improving the environment (see Patent Document 5 below). Moreover, as an active ingredient other than catechin contained in tea, a polysaccharide derived from tea having a molecular weight of about 40,000 and L-arabinose, D-ribose, D-glucose as main constituent sugars has a hypoglycemic action. A hypoglycemic agent, an antidiabetic agent, and a health food that use this polysaccharide as an active ingredient have been proposed (see Patent Document 6 below). Furthermore, an antihyperlipidemic agent comprising this polysaccharide as an active ingredient has been proposed (see Patent Document 7 below). In addition, a plasma cholesterol-lowering agent has been proposed comprising a polysaccharide obtained by extracting tea leaves with water or warm water, in particular, a polysaccharide having a molecular weight of about 20,000 to about 200,000 as an active ingredient (Patent Document 8 below). See).
However, the elucidation of the action of tea components has not been sufficiently performed, and there are many unknown parts. Therefore, the search for a tea component having an intestinal function improving action is very significant.
JP-A-3-151854 JP 58-201980 A JP-A-1-319421 JP 2003-61592 A JP-A-6-166618 JP-A 63-308001 JP-A-2-286620 JP-A-6-80580 Hara Kenji, Biochemistry and Application of Bioactive Lipids-Short Chain Fatty Acids, Koshobo, December 2000 Satoshi Inami, 16 outside, revised edition, dietary fiber, Daiichi Publishing Co., Ltd., May 1995

そこで本発明は、茶成分を有効成分とする腸内機能改善を提供することを目的とする。   Therefore, an object of the present invention is to provide intestinal function improvement using a tea ingredient as an active ingredient.

本発明者らは上記の点に鑑みて種々の検討を行った結果、茶の水乃至熱水抽出工程を経て得られる多糖類が優れた腸内機能改善作用を有することを見出した。   As a result of various studies in view of the above points, the present inventors have found that the polysaccharide obtained through the tea water or hot water extraction step has an excellent intestinal function improving action.

本発明は、上記の知見に基づいてなされたものであり、本発明の腸内機能改善剤は、請求項1記載の通り、茶の水乃至熱水抽出工程を経て得られる分子量40万以上の多糖類を有効成分とすることを特徴とする
た、本発明の腸内機能改善用医薬品は、請求項記載の通り、有効量の請求項1記載の腸内機能改善剤を配合してなることを特徴とする。
また、本発明の腸内機能改善用医薬部外品は、請求項記載の通り、有効量の請求項1記載の腸内機能改善剤を配合してなることを特徴とする。


The present invention has been made on the basis of the above findings, and the intestinal function improving agent of the present invention, as described in claim 1, has a molecular weight of 400,000 or more obtained through a tea water or hot water extraction step. It is characterized by using a polysaccharide as an active ingredient .
Also, intestinal function-improving medicament of the present invention, as claimed in claim 2, characterized in that by blending the intestinal function improving agent an effective amount of claim 1, wherein.
The quasi drug for improving intestinal function according to the present invention is characterized in that, as described in claim 3 , an effective amount of the intestinal function improving agent described in claim 1 is blended.


本発明における腸内機能改善剤は、茶の水乃至熱水抽出工程を経て得られる多糖類を有効成分とした新しい腸内機能改善剤であり、飲食品や医薬品などの口腔適用対象物に幅広く応用できる汎用性の高いものである。本発明における腸内機能改善剤は、摂取により、腸内の短鎖脂肪酸が増加することで腸内の機能が改善され、整腸作用や排便促進による便秘改善作用などを発揮することができる。また、本発明の腸内機能改善剤は、原料が従来から食用に供されている天然由来の素材であるため、人体への安全性が高く、副作用の心配をする必要なく長期にわたり継続的に服用できる。   The intestinal function-improving agent in the present invention is a new intestinal function-improving agent comprising a polysaccharide obtained through tea water or hot water extraction process as an active ingredient, and is widely used for oral application objects such as foods and drinks and pharmaceuticals. It is highly versatile. The intestinal function-improving agent in the present invention improves intestinal function by increasing short-chain fatty acids in the intestine when ingested, and can exert constipation improving action by promoting bowel regulation or defecation. In addition, since the intestinal function improving agent of the present invention is a naturally-derived material that has been conventionally used for food, it is highly safe to the human body and continuously for a long time without having to worry about side effects. Can be taken.

本発明において腸内機能改善剤の有効成分として用いられる茶の水乃至熱水抽出工程を経て得られる多糖類(茶多糖類)は、茶を水乃至熱水にて抽出して得られるものであれば水溶性の多糖類でも不溶性の多糖類でもよく、特に制限されるものではない。また一般的に多糖類とは、単糖またはオリゴ糖以外の糖類であり、重合度10以上のものを称する。なお、茶の水乃至熱水抽出工程を経て得られないセルロースなどの不溶性食物繊維は、本発明の有効成分には含まれない。   The polysaccharide (tea polysaccharide) obtained through the tea water or hot water extraction step used as an active ingredient of the intestinal function improving agent in the present invention is obtained by extracting tea with water or hot water. As long as it is a water-soluble polysaccharide or an insoluble polysaccharide, it is not particularly limited. In general, a polysaccharide is a saccharide other than a monosaccharide or oligosaccharide, and refers to a polymer having a polymerization degree of 10 or more. It should be noted that insoluble dietary fibers such as cellulose that are not obtained through the tea water or hot water extraction step are not included in the active ingredients of the present invention.

茶多糖類の分子量は、特に制限されるものではなく、どのような分子量であっても腸内の機能改善作用を発揮することができるが、とりわけ、分子量40万以上のものが、優れた腸内機能改善作用を発揮するため好ましい。所望する分子量を有する茶多糖類は、適宜濾過膜を選択することにより容易に得ることができる。分子量の上限値は特に制限されないので、どのような大きさの多糖類であってもよいが、好ましくは、膜孔径が1.0μmの精密濾過膜を透過できるものである。膜孔径が1.0μmの精密濾過膜を透過できない成分を含むと、ある一定の効果以上は得ることができず、好ましくない。   The molecular weight of the tea polysaccharide is not particularly limited, and can exert an intestinal function improving effect at any molecular weight. Particularly, those having a molecular weight of 400,000 or more have excellent intestinal properties. This is preferable because it exhibits an internal function improving action. Tea polysaccharides having a desired molecular weight can be easily obtained by appropriately selecting a filtration membrane. Since the upper limit of the molecular weight is not particularly limited, any size polysaccharide may be used, but it is preferably one that can pass through a microfiltration membrane having a membrane pore size of 1.0 μm. When a component that cannot pass through a microfiltration membrane having a membrane pore diameter of 1.0 μm is included, it is not preferable because a certain effect or more cannot be obtained.

本発明において腸内機能改善剤の有効成分として用いられる茶多糖類の構成糖は特に制限されるものではないが、好ましくは、少なくともガラクチュロン酸、ガラクトースおよびアラビノースを構成糖として含有していればよい。また、茶多糖類中に含有される構成糖の割合は特に制限されないが、好ましくはガラクチュロン酸、ガラクトースおよびアラビノースの合計の構成比率が茶多糖類中の構成糖全体の15重量%以上がよく、さらに好ましくは30重量%以上がよい。なお、ガラクチュロン酸、ガラクトースおよびアラビノースの各成分の構成比は特に制限されるものではない。   In the present invention, the constituent sugars of the tea polysaccharide used as an active ingredient of the intestinal function improving agent are not particularly limited, but preferably contain at least galacturonic acid, galactose and arabinose as constituent sugars. . Further, the ratio of the constituent sugar contained in the tea polysaccharide is not particularly limited, but preferably the total constituent ratio of galacturonic acid, galactose and arabinose is 15% by weight or more of the total constituent sugar in the tea polysaccharide, More preferably, it is 30% by weight or more. In addition, the component ratio of each component of galacturonic acid, galactose, and arabinose is not particularly limited.

以下に、本発明の腸内機能改善剤の製造方法について詳しく説明する。   Below, the manufacturing method of the intestinal function improving agent of this invention is demonstrated in detail.

本発明における茶とは、ツバキ科に属する茶樹(Camellia sinensis)から得られる葉、茎、木部、根、実のいずれか、あるいはこれらの2種類以上の混合物を意味し、生あるいは乾燥物の別を問わない。また、既製の紅茶、プアール茶などの発酵茶、ウーロン茶、包種茶などの半発酵茶、緑茶、釜煎り緑茶、ほうじ茶などの不発酵茶のいずれであってもよいし、また、これらの2種類以上の混合物であってもよい。   The tea in the present invention means any of leaves, stems, xylem, roots and fruits obtained from a tea tree (Camellia sinensis) belonging to the camellia family, or a mixture of two or more of these, raw or dried products. It does n’t matter. Moreover, it may be any of ready-made black tea, fermented tea such as puer tea, semi-fermented tea such as oolong tea and baked tea, non-fermented tea such as green tea, kettle roasted green tea, and roasted tea. It may be a mixture of more than one type.

本発明の腸内機能改善剤の有効成分として用いられる茶多糖類は、例えば、茶の水乃至熱水抽出物から得ることができる。この茶抽出物は、上記茶をそのまま若しくは粉砕物とした後抽出操作に供するか、乾燥後必要に応じて粉砕して抽出操作に供して調製することができる。乾燥粉砕物は、茶の葉、茎、木部、根、実をそのまま乾燥した後粉砕するか、または生のまま細かく切断した後乾燥することによって調製することができる。   The tea polysaccharide used as an active ingredient of the intestinal function improving agent of the present invention can be obtained from tea water or hot water extract, for example. This tea extract can be prepared by subjecting the tea as it is or after pulverization to an extraction operation, or after drying and pulverizing if necessary, followed by an extraction operation. The dried pulverized product can be prepared by drying the tea leaves, stems, xylem, roots and fruits as they are and then pulverizing them, or cutting them raw and then drying them.

抽出方法としては、水乃至熱水を用いた一般的な方法を採用することができ、例えば、水、温水、熱水中に茶(そのまま若しくは粗末・細切物)、またはそれらの乾燥粉砕物(粉末など)を浸漬する方法、加温し攪拌しながら抽出を行う方法などが挙げられる。得られた抽出液は必要に応じて濾過または遠心分離などにより固形物を除去した後、これをそのまま用いてもよく、さらに濃縮して用いても、あるいはこれを凍結乾燥あるいはスプレードライなどの方法により粉末化して用いてもよい。さらに、カテキン類などの茶多糖類以外の成分を取り除いて用いてもよい。一般的には茶抽出物の市販品を用いればよく、このような市販品としては、例えば、東京フードテクノ(株)「ポリフェノン」、太陽化学(株)「サンフェノン」、(株)伊藤園「テアフラン」などを例示することができる。   As an extraction method, a general method using water or hot water can be employed. For example, tea (as it is or coarsely divided or shredded product) in water, hot water or hot water, or a dry pulverized product thereof. Examples include a method of immersing (such as powder) and a method of performing extraction while heating and stirring. The obtained extract may be used as it is after removing solids by filtration or centrifugation as necessary, and may be used as it is, or it may be further concentrated, or it may be freeze-dried or spray-dried. May be used after being powdered. Furthermore, you may remove and use components other than tea polysaccharides, such as catechins. In general, commercially available tea extracts may be used. Examples of such commercially available products include Tokyo Food Techno Co., Ltd. “Polyphenone”, Taiyo Kagaku Co., Ltd. “Sunphenon”, and ITO EN Co., Ltd. And the like.

茶抽出物から茶多糖類を調製するには、例えば、茶抽出物に50−90%エタノール水溶液などの含水有機溶媒あるいはエタノールなどの有機溶媒を加えてよく攪拌し、このとき生じた不溶物を遠心分離などにより集める。そしてこの不溶物に再度上記のエタノール水溶液などの含水有機溶媒あるいはエタノールなどの有機溶媒を加えて十分に攪拌後、遠心分離などを用いて不溶物を集める。この操作を何回か繰り返した後、集めた不溶物を必要に応じて真空乾燥、凍結乾燥あるいはスプレードライなどの方法により乾燥させれば、粗茶多糖類を得ることができる。   To prepare a tea polysaccharide from a tea extract, for example, a water-containing organic solvent such as 50-90% ethanol aqueous solution or an organic solvent such as ethanol is added to the tea extract and stirred well. Collect by centrifugation. Then, a water-containing organic solvent such as the above ethanol aqueous solution or an organic solvent such as ethanol is added to the insoluble matter again, and after sufficient stirring, the insoluble matter is collected using centrifugation or the like. After repeating this operation several times, if the collected insoluble matter is dried by a method such as vacuum drying, freeze drying, spray drying or the like, crude tea polysaccharides can be obtained.

この粗茶多糖類から茶多糖類を精製するには、まず得られた粗茶多糖類に水などを加えてよく攪拌し懸濁液とする。そしてこの懸濁液に対して、分子量の大きさによって分離する方法、例えば、精密濾過、限外濾過あるいはゲル濾過などを採用し、所望とする分子量に合わせて適宜濾過膜あるいはゲル濾過材を選択し分画することで行うことができる。例えば、分子量40万以上の茶多糖類を精製するには、該懸濁液を、分画分子量が40万の限外濾過膜へ透過させることにより行えばよい。なお、所望する分子量の茶多糖類は、まず、茶抽出物から所望する分子量の画分を得、この画分に50−90%エタノール水溶液などの含水有機溶媒あるいはエタノールなどの有機溶媒を加えて得るようにしてもよい。   In order to purify the tea polysaccharide from the crude tea polysaccharide, first, water or the like is added to the obtained crude tea polysaccharide and stirred well to obtain a suspension. A method of separating the suspension according to the molecular weight, such as microfiltration, ultrafiltration or gel filtration, is adopted, and a filtration membrane or gel filtration material is appropriately selected according to the desired molecular weight. This can be done by fractionating. For example, in order to purify a tea polysaccharide having a molecular weight of 400,000 or more, the suspension may be permeated through an ultrafiltration membrane having a fractional molecular weight of 400,000. For the desired molecular weight tea polysaccharide, first, a desired molecular weight fraction is obtained from the tea extract, and a water-containing organic solvent such as 50-90% ethanol aqueous solution or an organic solvent such as ethanol is added to this fraction. You may make it obtain.

また、一度分画した成分を濾過膜あるいはゲル濾過材の大きさを換えて、さらに細かく分離精製することもできる。例えば、分子量40万以上の成分から、さらに200万以上の成分を分画することや、膜孔径が1.0μmの精密濾過膜を透過できかつ分子量が40万以上の成分を分画することも可能である。   The components once fractionated can be further finely separated and purified by changing the size of the filtration membrane or gel filtration material. For example, it is possible to fractionate more than 2 million components from components having a molecular weight of 400,000 or more, or fractionate components that can pass through a microfiltration membrane having a membrane pore diameter of 1.0 μm and have a molecular weight of 400,000 or more. Is possible.

以上のように、得ようとする茶多糖類の大きさに合わせて、適宜濾過膜あるいはゲル濾過材を選択することにより、粗茶多糖類から精製された茶多糖類を得ることができる。   As described above, the tea polysaccharide purified from the crude tea polysaccharide can be obtained by appropriately selecting a filtration membrane or gel filtration material in accordance with the size of the tea polysaccharide to be obtained.

さらに、粗茶多糖類を水、温水あるいは熱水に懸濁させた後、沈殿物を遠心分離や濾過などにより集め、また、集めた沈殿物を上記の操作を繰り返すことによって洗浄することで、上記の粗茶多糖類から不溶性の茶多糖類を精製することができる。上記の操作で得られる水溶性画分からは水溶性の茶多糖類を回収することができる。また、例えば、粗茶多糖類をあらかじめ分子量40万以上の茶多糖類画分に分画後、不溶性の多糖類を遠心分離や濾過により集めるといったことも可能である。このようにして得られた不溶性の茶多糖類と水溶性の茶多糖類は、各々単独で用いてもよいし、両者を適当な比率で混合して用いてもよい。   Furthermore, after suspending the crude tea polysaccharide in water, warm water or hot water, the precipitate is collected by centrifugation, filtration, etc., and the collected precipitate is washed by repeating the above operation, Insoluble tea polysaccharides can be purified from the crude tea polysaccharides. Water-soluble tea polysaccharides can be recovered from the water-soluble fraction obtained by the above operation. In addition, for example, the crude tea polysaccharide can be fractionated in advance into a tea polysaccharide fraction having a molecular weight of 400,000 or more, and then the insoluble polysaccharide can be collected by centrifugation or filtration. The insoluble tea polysaccharide and water-soluble tea polysaccharide obtained in this way may be used alone or in a mixture at an appropriate ratio.

以上のようにして得られた茶多糖類は、必要に応じ凍結乾燥やスプレードライなどの方法により乾燥し粉末化することができる。また他の方法としては、これらに50−90%となるようにエタノールを加えて、茶多糖類を沈殿させ、沈殿物を回収後乾燥させて粉末化させることもできる。   The tea polysaccharide obtained as described above can be dried and powdered by a method such as freeze drying or spray drying, if necessary. Moreover, as another method, ethanol can be added to these so that it may become 50-90%, a tea polysaccharide can be precipitated, and it can also be made into powder by drying after collect | recovering deposits.

上記のような方法で調製した腸内機能改善剤は、日常多量に飲用している茶から得た成分であるため、安全性が高く、かつ大量製造が可能である。また、製造も比較的簡便に行うことができる。   Since the intestinal function improving agent prepared by the method as described above is a component obtained from tea that is drunk daily in large quantities, it is highly safe and can be mass-produced. Further, the production can be performed relatively easily.

本発明の腸内機能改善剤は、上記のような方法にて得られた茶多糖類の混合物をそのまま用いてもよいし、茶多糖類をイオン交換樹脂、吸着樹脂、ゲル濾過材などを用いてさらに細かく精製して得られた個々の茶多糖類を用いてもよい。また、精製して得られた2種類以上の茶多糖類を所望とする混合比で組み合わせて用いてもよい。いずれの用い方であっても、本発明の腸内機能改善は、腸内の短鎖脂肪酸の増加作用などに基づく腸内環境改善や腸内代謝改善などにより、腸内のpHを低下させ、ウェルシュ菌などの悪玉菌の増殖を抑制し、悪玉菌の作り出す腐敗産物や細菌毒素の生成を抑えることで、整腸作用や排便促進による便秘改善作用などを発揮することができる。なお、ここで短鎖脂肪酸とは、一般的に解釈されるものであればよく、酢酸、プロピオン酸、イソ酪酸、酪酸、イソ吉草酸、吉草酸、乳酸、リンゴ酸、コハク酸などから選ばれる少なくとも1つを意味するものと解釈してもよいし、これらを総括した総短鎖脂肪酸を意味するものと解釈してもよい。   As the intestinal function improving agent of the present invention, the mixture of tea polysaccharides obtained by the method as described above may be used as it is, or the tea polysaccharide is used as an ion exchange resin, an adsorption resin, a gel filtration material or the like. Individual tea polysaccharides obtained by further fine purification may be used. Further, two or more kinds of tea polysaccharides obtained by purification may be used in combination at a desired mixing ratio. Regardless of how it is used, the intestinal function improvement of the present invention reduces the intestinal pH by improving the intestinal environment and intestinal metabolism based on the increase action of short-chain fatty acids in the intestine, By suppressing the growth of bad bacteria such as Clostridium perfringens and suppressing the production of spoilage products and bacterial toxins produced by the bad bacteria, it is possible to exert an effect of improving constipation by promoting bowel regulation or defecation. Here, the short-chain fatty acid may be anything that is generally interpreted, and is selected from acetic acid, propionic acid, isobutyric acid, butyric acid, isovaleric acid, valeric acid, lactic acid, malic acid, succinic acid, and the like. It may be interpreted as meaning at least one, or may be interpreted as meaning a total short-chain fatty acid summed up.

本発明の腸内機能改善剤は、口腔適用対象物に有効量を配合することで、優れた腸内機能改善効果を発揮する。本発明において、口腔適用対象物とは、口に含むことができるものであれば何でもよいが、茶多糖類が腸内に到達することができる、飲食品、医薬品、医薬部外品などを好適に例示することができる。   The intestinal function improving agent of the present invention exhibits an excellent intestinal function improving effect by blending an effective amount in an oral application target. In the present invention, the oral application target may be anything as long as it can be contained in the mouth, but is preferably a food / drink, a pharmaceutical, a quasi-drug, or the like that allows the tea polysaccharide to reach the intestine. Can be exemplified.

本発明の口腔適用対象物は、腸内機能改善剤の有効成分となる茶多糖類を配合することができるものであればどのような形態であってもよく、例えば、水溶液や混濁液や乳化物などの液状形態であっても、ゲル状やペースト状の半固形状形態であっても、粉末や顆粒やカプセルやタブレットなどの固形状形態であってもよい。   The oral application target of the present invention may be in any form as long as it can be blended with a tea polysaccharide that is an active ingredient of an intestinal function improving agent, for example, an aqueous solution, a turbid solution, or an emulsification. It may be in a liquid form such as a product, in a semi-solid form such as a gel or paste, or in a solid form such as powder, granule, capsule or tablet.

本発明における口腔適用対象物のうち、飲食品としては、例えば、即席食品類(即席めん、カップめん、レトルト・調理食品、調理缶詰め、電子レンジ食品、即席味噌汁・吸い物、スープ缶詰め、フリーズドライ食品など)、炭酸飲料、柑橘類(グレープフルーツ、オレンジ、レモンなど)の果汁や果汁飲料や果汁入り清涼飲料、柑橘類の果肉飲料や果粒入り果実飲料、トマト、ピーマン、セロリ、ウリ、ニンジン、ジャガイモ、アスパラガスなどの野菜を含む野菜系飲料、豆乳・豆乳飲料、コーヒー飲料、お茶飲料、粉末飲料、濃縮飲料、スポーツ飲料、栄養飲料、アルコール飲料やタバコなどの嗜好飲料・嗜好品類、パン、マカロニ・スパゲッティ、麺類、ケーキミックス、唐揚げ粉、パン粉、ギョーザの皮などの小麦粉製品、キャラメル・キャンディー、チューイングガム、チョコレート、クッキー・ビスケット、ケーキ・パイ、スナック・クラッカー、和菓子・米菓子・豆菓子、デザート菓子などの菓子類、しょうゆ、みそ、ソース類、トマト加工調味料、みりん類、食酢類、甘味料などの基礎調味料、風味調味料、調理ミックス、カレーの素類、たれ類、ドレッシング類、めんつゆ類、スパイス類などの複合調味料・食品類、バター、マーガリン類、マヨネーズ類、植物油などの油脂類、牛乳・加工乳、乳飲料、ヨーグルト類、乳酸菌飲料、チーズ、アイスクリーム類、調製粉乳類、クリームなどの乳・乳製品、素材冷凍食品、半調理冷凍食品、調理済み冷凍食品などの冷凍食品、水産缶詰め、果実缶詰め・ペースト類、魚肉ハム・ソーセージ、水産練り製品、水産珍味類、水産乾物類、佃煮類などの水産加工品、畜産缶詰め・ペースト類、畜肉缶詰め、果実缶詰め、ジャム・マーマレード類、漬物・煮豆類、農産乾物類、シリアル(穀物加工品)などの農産加工品、ベビーフード、ふりかけ・お茶漬けのりなどの市販食品などが挙げられる。   Among the oral application objects in the present invention, as foods and drinks, for example, instant foods (immediate noodles, cup noodles, retort / cooked food, cooking canned food, microwave food, instant miso soup / soup, canned soup, freeze-dried food, etc. ), Carbonated drinks, citrus fruit juices (grapefruit, orange, lemon, etc.), juice drinks, soft drinks with juice, citrus fruit drinks and fruit drinks, tomatoes, peppers, celery, cucumbers, carrots, potatoes, asparagus Vegetable beverages including vegetables such as soy milk and soy milk beverages, coffee beverages, tea beverages, powdered beverages, concentrated beverages, sports beverages, nutritional beverages, alcoholic beverages, tobacco beverages and other favorite beverages and luxury products, bread, macaroni and spaghetti, Noodles, cake mix, deep-fried flour, bread crumbs, gyoza peel and other flour products, caramel・ Candies, chewing gum, chocolate, cookies / biscuits, cakes / pies, snacks / crackers, Japanese confectionery / rice confectionery / bean confectionery, dessert confectionery, soy sauce, miso, sauces, tomato processed seasonings, mirin, vinegar , Basic seasonings such as sweeteners, flavor seasonings, cooking mixes, curry ingredients, sauces, dressings, noodle soups, spices and other complex seasonings and foods, butter, margarines, mayonnaise, Fats and oils such as vegetable oil, milk / processed milk, milk drinks, yogurts, lactic acid bacteria drinks, cheese, ice creams, prepared powdered milk, milk and other dairy products such as cream, frozen material, semi-cooked frozen food, cooked frozen Frozen foods such as food, canned fish, canned fruits and pastes, fish ham and sausage, marine products, marine delicacy Processed fishery products such as dried fishery products, boiled fish, canned livestock cans / pastes, canned meat, canned fruits, jams / marmalades, pickles / boiled beans, dried agricultural products, processed cereals (cereal processed products) , Baby food, commercial foods such as sprinkles and ochazukenori.

また、本発明の口腔適用対象物のうち、医薬品としては、日本薬局方に収められている医薬品で口に含むことができれば特に限定されるものではなく、その製剤形態としては、例えば、エアゾール剤、液剤、エキス剤、エリキシル剤、カプセル剤、顆粒剤、丸剤、散剤、酒精剤、錠剤、シロップ剤、浸剤・煎剤、トローチ剤、芳香水剤、リモナーゼ剤などが挙げられる。医薬部外品としては、厚生労働大臣が指定した医薬部外品で口に含むことができれば特に限定されるものではなく、例えば、内服液剤、健康飲料、消毒剤、消毒保護剤、ビタミン含有保健剤などが挙げられる。   In addition, among the oral applied objects of the present invention, the pharmaceutical is not particularly limited as long as it can be contained in the mouth with the pharmaceuticals contained in the Japanese Pharmacopoeia. , Liquids, extracts, elixirs, capsules, granules, pills, powders, spirits, tablets, syrups, dip / decoction, troches, fragrances, limonases and the like. The quasi-drug is not particularly limited as long as it is a quasi-drug specified by the Minister of Health, Labor and Welfare and can be included in the mouth. For example, oral liquids, health drinks, disinfectants, antiseptics, vitamin-containing health care Agents and the like.

口腔適用対象物への本発明の腸内機能改善剤の配合方法は特に制限されるものではない。例えば、口腔適用対象物の調製段階において本発明の茶多糖類を粉末状形態や液状形態にて添加し、均一化することにより行えばよい。なお、口腔適用対象物を調製する際は、必要に応じて、着色剤、抗酸化剤、香料、矯味剤、界面活性剤、溶解補助剤、保存剤、甘味料などを適宜組み合わせて用いてもよい。   The method of blending the intestinal function improving agent of the present invention into the oral application target is not particularly limited. For example, it may be performed by adding the tea polysaccharide of the present invention in a powder form or a liquid form in the preparation stage of the oral application target and homogenizing it. In addition, when preparing the oral application target, a coloring agent, an antioxidant, a fragrance, a corrigent, a surfactant, a solubilizing agent, a preservative, a sweetener, and the like may be used in combination as appropriate. Good.

口腔適用対象物に対する本発明の腸内機能改善剤の配合量は、特に制限されず、対象となる口腔適用対象物により配合量を適宜設定することが好ましい。一般的には、最終製品中で0.1重量%以上であることが好ましく、1重量%以上であることがより好ましく、5重量%以上であることが最も好ましい。配合量の上限値は、最終製品中で50重量%であることが好ましい。腸内機能改善剤の配合量が0.1重量%より少ない場合には、目的とする腸内機能改善効果が期待できない恐れがある。一方、過剰量を配合した場合、口腔適用対象物が飲食品の場合には飲食品本来の味覚が損なわれることや、ある一定の効果以上は得ることができずに経済的に不利となることがある。   The blending amount of the intestinal function improving agent of the present invention with respect to the oral application target is not particularly limited, and it is preferable to appropriately set the blending amount according to the target oral application target. Generally, it is preferably 0.1% by weight or more in the final product, more preferably 1% by weight or more, and most preferably 5% by weight or more. The upper limit of the amount is preferably 50% by weight in the final product. When the blending amount of the intestinal function improving agent is less than 0.1% by weight, the target intestinal function improving effect may not be expected. On the other hand, when an excessive amount is blended, when the oral application target is a food or drink, the original taste of the food or drink is impaired, or a certain effect or more cannot be obtained, which is economically disadvantageous. There is.

本発明の腸内機能改善剤は、上記のように口腔適用対象物に配合して摂取してもよいが、そのまま単独で摂取することもできる。その摂取量は、摂取形態、年齢、体重などにより異なるが、特に制限されるものではない。   The intestinal function-improving agent of the present invention may be ingested by being mixed with the oral application target as described above, but can also be ingested as it is. The intake amount varies depending on the intake form, age, weight, etc., but is not particularly limited.

なお、本発明の腸内機能改善剤は、従来から知られている腸内機能改善作用を有する物質、例えば、オリゴ糖や茶カテキンなどと併用して用いても何ら問題は生じない。これらの物質と併用した場合には、より優れた腸内機能改善効果を期待することができる。   The intestinal function improving agent of the present invention does not cause any problems even when used in combination with conventionally known substances having an intestinal function improving action, such as oligosaccharides and tea catechins. When used in combination with these substances, a better intestinal function improving effect can be expected.

以下に、製造例、試験例および処方例を挙げ、本発明をさらに詳しく説明する。ただし、本発明はこれに限定されるものではない。   Hereinafter, the present invention will be described in more detail with reference to production examples, test examples and formulation examples. However, the present invention is not limited to this.

製造例1:緑茶の熱水抽出工程を経て得られる粗茶多糖類の調製
緑茶5kgを90℃の熱水50Lに加え、ときどき攪拌しながら30分間抽出した。得られた抽出液を濾過し減圧下に濃縮後、スプレードライにより乾燥させ、粉末状の緑茶抽出物を約1.5kg得た。
このようにして得られた緑茶抽出物1.5kgに2Lの70%エタノールを加えてよく攪拌した。不溶物を遠心分離して回収し、この不溶物に2Lの70%エタノールを加えて十分に攪拌後、遠心分離にて不溶物を集めた。この操作をさらに2回繰り返し、不溶物として粗茶多糖類約200gを得た。
Production Example 1: Preparation of Crude Tea Polysaccharide Obtained through Hot Water Extraction Step of Green Tea 5 kg of green tea was added to 50 L of hot water at 90 ° C. and extracted for 30 minutes with occasional stirring. The obtained extract was filtered, concentrated under reduced pressure, and then dried by spray drying to obtain about 1.5 kg of a powdery green tea extract.
2 L of 70% ethanol was added to 1.5 kg of the green tea extract obtained in this manner and stirred well. Insoluble matters were collected by centrifugation, 2 L of 70% ethanol was added to the insoluble matters, and after sufficient stirring, the insoluble matters were collected by centrifugation. This operation was further repeated twice to obtain about 200 g of a crude tea polysaccharide as an insoluble material.

製造例2:緑茶の熱水抽出工程を経て得られる精製茶多糖類の調製(その1)
緑茶熱水抽出物(ポリフェノンG、東京フードテクノ(株)製)1.5kgに2Lの70%エタノールを加えてよく攪拌した。不溶物を遠心分離して回収し、この不溶物に2Lの70%エタノールを加えて十分に攪拌後、遠心分離にて不溶物を集めた。この操作をさらに2回繰り返し、不溶物として粗茶多糖類約350gを得た。
この粗茶多糖類350gに5Lの水を加えてよく攪拌して懸濁液とし、この懸濁液を分画分子量40万の限外濾過膜(ポリスルフォン膜PS/400K、スペクトラム社製)を用いて分子量40万以上の成分と分子量40万未満の成分に分画した。得られた各成分を濃縮し凍結乾燥して、分子量40万以上の茶多糖類画分222gと分子量40万未満の茶多糖類画分102gを得た。この分子量40万以上の茶多糖類中に含有される構成糖の割合は、ガラクチュロン酸、ガラクトースおよびアラビノースの合計の構成比率が茶多糖類中の構成糖全体の約30重量%であった。
Production Example 2: Preparation of purified tea polysaccharide obtained through a hot water extraction step of green tea (Part 1)
2 L of 70% ethanol was added to 1.5 kg of green tea hot water extract (Polyphenon G, manufactured by Tokyo Food Techno Co., Ltd.) and stirred well. Insoluble matters were collected by centrifugation, 2 L of 70% ethanol was added to the insoluble matters, and after sufficient stirring, the insoluble matters were collected by centrifugation. This operation was further repeated twice to obtain about 350 g of a crude tea polysaccharide as an insoluble material.
5 L of water was added to 350 g of this crude tea polysaccharide and stirred well to obtain a suspension. This suspension was subjected to ultrafiltration membrane (polysulfone membrane PS / 400K, manufactured by Spectrum) having a molecular weight cut off of 400,000. Thus, it was fractionated into a component having a molecular weight of 400,000 or more and a component having a molecular weight of less than 400,000. Each component obtained was concentrated and freeze-dried to obtain 222 g of a tea polysaccharide fraction having a molecular weight of 400,000 or more and 102 g of a tea polysaccharide fraction having a molecular weight of less than 400,000. The ratio of the constituent sugar contained in the tea polysaccharide having a molecular weight of 400,000 or more was such that the total constituent ratio of galacturonic acid, galactose and arabinose was about 30% by weight of the whole constituent sugar in the tea polysaccharide.

製造例3:緑茶の熱水抽出工程を経て得られる精製茶多糖類の調製(その2)
緑茶熱水抽出物(ポリフェノンG、東京フードテクノ(株)製)2kgに10Lの70%エタノールを加えてよく攪拌した。不溶物を遠心分離して回収し、この不溶物に4Lの70%エタノールを加え十分に攪拌後、遠心分離にて不溶物を集めた。この操作をさらに2回繰り返し、不溶物として粗茶多糖類約256gを得た。
この粗茶多糖類256gに10Lの水を加えてよく攪拌して懸濁液とし、分画分子量40万の限外濾過膜(ポリスルフォン膜PS/400K、スペクトラム社製)を用いて分子量40万未満の成分を除去し、分子量40万以上の画分を濃縮して集めた。
次に、得られた分子量40万以上の画分を遠心分離にて沈殿物を回収した。沈殿物を2Lの水で洗浄する操作を2回繰り返した後、これを凍結乾燥し、分子量40万以上の不溶性の茶多糖類約118gを得た。
一方、遠心分離の際に得られた水溶性画分は凍結乾燥し、分子量40万以上の水溶性の茶多糖類約56gを得た。
また、限外濾過で得られた分子量40万未満の成分を濃縮し凍結乾燥して、分子量40万未満の茶多糖類約50gを得た。
Production Example 3: Preparation of purified tea polysaccharide obtained through a hot water extraction step of green tea (part 2)
10 L of 70% ethanol was added to 2 kg of green tea hot water extract (Polyphenon G, manufactured by Tokyo Food Techno Co., Ltd.) and stirred well. The insoluble matter was collected by centrifugation, 4 L of 70% ethanol was added to the insoluble matter, and after sufficient stirring, the insoluble matter was collected by centrifugation. This operation was further repeated twice to obtain about 256 g of crude tea polysaccharide as an insoluble material.
10 g of water is added to 256 g of this crude tea polysaccharide and stirred well to obtain a suspension, and the molecular weight is less than 400,000 using an ultrafiltration membrane having a fractional molecular weight of 400,000 (polysulfone membrane PS / 400K, manufactured by Spectrum). These fractions were removed and fractions having a molecular weight of 400,000 or more were concentrated and collected.
Next, a precipitate was collected by centrifuging the obtained fraction having a molecular weight of 400,000 or more. The operation of washing the precipitate with 2 L of water was repeated twice and then freeze-dried to obtain about 118 g of insoluble tea polysaccharide having a molecular weight of 400,000 or more.
On the other hand, the water-soluble fraction obtained upon centrifugation was freeze-dried to obtain about 56 g of water-soluble tea polysaccharide having a molecular weight of 400,000 or more.
Further, the component having a molecular weight of less than 400,000 obtained by ultrafiltration was concentrated and freeze-dried to obtain about 50 g of tea polysaccharide having a molecular weight of less than 400,000.

製造例4:緑茶の熱水抽出工程を経て得られる精製茶多糖類の調製(その3)
緑茶熱水抽出物(ポリフェノンG、東京フードテクノ(株)製)1.5kgに2Lの70%エタノールを加えてよく攪拌した。不溶物を遠心分離して回収し、この不溶物に2Lの70%エタノールを加えて十分に攪拌後、遠心分離にて不溶物を集めた。この操作をさらに2回繰り返し、不溶物として粗茶多糖類約350gを得た。
この粗茶多糖類350gに5Lの水を加えてよく攪拌して懸濁液とし、この懸濁液を膜孔径が1.0μmの精密濾過膜(ポリプロピレン膜TCP−1、アドバンテック社製)を用いて1.0μmより大きな成分を除去した。得られた透過液を分画分子量40万の限外濾過膜(ポリスルフォン膜PS/400K、スペクトラム社製)を用いて分子量40万以上の成分と分子量40万未満の成分に分画した。得られた各成分を濃縮し凍結乾燥して、分子量40万以上の茶多糖類画分222gと分子量40万未満の茶多糖類画分102gを得た。
Production Example 4: Preparation of purified tea polysaccharide obtained through a hot water extraction process of green tea (part 3)
2 L of 70% ethanol was added to 1.5 kg of green tea hot water extract (Polyphenon G, manufactured by Tokyo Food Techno Co., Ltd.) and stirred well. Insoluble matters were collected by centrifugation, 2 L of 70% ethanol was added to the insoluble matters, and after sufficient stirring, the insoluble matters were collected by centrifugation. This operation was further repeated twice to obtain about 350 g of a crude tea polysaccharide as an insoluble material.
5 L of water was added to 350 g of this crude tea polysaccharide and stirred well to obtain a suspension. This suspension was used with a microfiltration membrane (polypropylene membrane TCP-1, manufactured by Advantech) having a membrane pore size of 1.0 μm. Components larger than 1.0 μm were removed. The obtained permeate was fractionated into a component having a molecular weight of 400,000 or more and a component having a molecular weight of less than 400,000 using an ultrafiltration membrane having a fractional molecular weight of 400,000 (polysulfone membrane PS / 400K, manufactured by Spectrum). Each component obtained was concentrated and freeze-dried to obtain 222 g of a tea polysaccharide fraction having a molecular weight of 400,000 or more and 102 g of a tea polysaccharide fraction having a molecular weight of less than 400,000.

製造例5:烏龍茶の熱水抽出工程を経て得られる精製茶多糖類の調製
中国産烏龍茶5kgを90℃の熱水50Lに加え、ときどき攪拌しながら30分間抽出した。得られた抽出液を濾過し減圧下に濃縮後、スプレードライにより乾燥させ、粉末状の烏龍茶抽出物を約1.5kg得た。
このようにして得られた烏龍茶抽出物1.5kgに2Lの70%エタノールを加えてよく攪拌した。不溶物を遠心分離して回収し、この不溶物に2Lの70%エタノールを加えて十分に攪拌後、遠心分離にて不溶物を集めた。この操作をさらに2回繰り返し、不溶物として粗茶多糖類約200gを得た。
この粗茶多糖類200gに4Lの水を加えてよく攪拌して懸濁液とし、この懸濁液を製造例2と同様に分画分子量40万の限外濾過膜(ポリスルフォン膜PS/400K、スペクトラム社製)を用いて分画後、濃縮し凍結乾燥して、分子量40万以上の茶多糖類画分87gと分子量40万未満の茶多糖類画分90gを得た。
Production Example 5 Preparation of Purified Tea Polysaccharide Obtained through Hot Water Extraction Step of Oolong Tea 5 kg of Chinese Oolong tea was added to 50 L of hot water at 90 ° C. and extracted for 30 minutes with occasional stirring. The obtained extract was filtered, concentrated under reduced pressure, and then dried by spray drying to obtain about 1.5 kg of powdered oolong tea extract.
2 L of 70% ethanol was added to 1.5 kg of the oolong tea extract thus obtained and stirred well. Insoluble matters were collected by centrifugation, 2 L of 70% ethanol was added to the insoluble matters, and after sufficient stirring, the insoluble matters were collected by centrifugation. This operation was further repeated twice to obtain about 200 g of a crude tea polysaccharide as an insoluble material.
To 200 g of this crude tea polysaccharide, 4 L of water was added and stirred well to obtain a suspension. This suspension was subjected to ultrafiltration membrane (polysulfone membrane PS / 400K, And then concentrated and freeze-dried to obtain 87 g of a tea polysaccharide fraction having a molecular weight of 400,000 or more and 90 g of a tea polysaccharide fraction having a molecular weight of less than 400,000.

製造例6:紅茶の熱水抽出工程を経て得られる精製茶多糖類の調製
インド産紅茶5kgを90℃の熱水50Lに加え、ときどき攪拌しながら30分間抽出した。得られた抽出液を濾過し減圧下に濃縮後、スプレードライにより乾燥させ、粉末状の紅茶抽出物を約1.5kg得た。
このようにして得られた紅茶抽出物1.5kgに2Lの70%エタノールを加えてよく攪拌した。不溶物を遠心分離して回収し、この不溶物に2Lの70%エタノールを加えて十分に攪拌後、遠心分離にて不溶物を集めた。この操作をさらに2回繰り返し、不溶物として粗茶多糖類約210gを得た。
この粗茶多糖類200gに4Lの水を加えてよく攪拌して懸濁液とし、この懸濁液を製造例2と同様に分画分子量40万の限外濾過膜(ポリスルフォン膜PS/400K、スペクトラム社製)を用いて分画後、濃縮し凍結乾燥して、分子量40万以上の茶多糖類画分80gと分子量40万未満の茶多糖類画分96gを得た。
Production Example 6: Preparation of purified tea polysaccharide obtained through hot water extraction step of black tea 5 kg of Indian black tea was added to 50 L of hot water at 90 ° C. and extracted for 30 minutes with occasional stirring. The obtained extract was filtered, concentrated under reduced pressure, and then dried by spray drying to obtain about 1.5 kg of a powdery black tea extract.
To 1.5 kg of the black tea extract thus obtained, 2 L of 70% ethanol was added and stirred well. Insoluble matters were collected by centrifugation, 2 L of 70% ethanol was added to the insoluble matters, and after sufficient stirring, the insoluble matters were collected by centrifugation. This operation was further repeated twice to obtain about 210 g of a crude tea polysaccharide as an insoluble material.
To 200 g of this crude tea polysaccharide, 4 L of water was added and stirred well to obtain a suspension. This suspension was subjected to ultrafiltration membrane (polysulfone membrane PS / 400K, And then concentrated and freeze-dried to obtain 80 g of a tea polysaccharide fraction having a molecular weight of 400,000 or more and 96 g of a tea polysaccharide fraction having a molecular weight of less than 400,000.

製造例7:緑茶の熱水抽出工程を経て得られる精製茶多糖類の調製(その4)
粉砕した緑茶1kgに70%エタノール水溶液10Lを加えて室温で12時間攪拌した。不溶性成分を濾過して回収し、再度上記と同量の70%エタノール水溶液を加えて8時間攪拌した。得られた不溶性成分に5Lの70%エタノール水溶液を加え4時間攪拌し不溶性成分を洗浄した。この操作をもう一度繰り返し、エタノール処理した緑茶葉500gを得た。
エタノール処理した緑茶葉500gを90℃の熱水5Lに加え、時々攪拌しながら30分間抽出した。得られた抽出液3Lを分画分子量40万以上の限外濾過膜(ポリスルフォン膜PS/400K、スペクトラム社製)を用いて処理し、水溶性の分子量40万以上の茶多糖類40gと分子量40万未満の茶多糖類50gを得た。
Production Example 7: Preparation of purified tea polysaccharide obtained through a hot water extraction step of green tea (Part 4)
To 1 kg of crushed green tea, 10 L of 70% ethanol aqueous solution was added and stirred at room temperature for 12 hours. Insoluble components were collected by filtration, and the same amount of 70% aqueous ethanol solution was added again and stirred for 8 hours. To the obtained insoluble component, 5 L of 70% ethanol aqueous solution was added and stirred for 4 hours to wash the insoluble component. This operation was repeated once more to obtain 500 g of ethanol-treated green tea leaves.
500 g of ethanol-treated green tea leaves were added to 5 L of hot water at 90 ° C., and extracted for 30 minutes with occasional stirring. The resulting extract 3L was treated with an ultrafiltration membrane having a fractional molecular weight of 400,000 or more (polysulfone membrane PS / 400K, manufactured by Spectrum), and 40 g of a water-soluble tea polysaccharide having a molecular weight of 400,000 or more and a molecular weight. 50 g of tea polysaccharide less than 400,000 was obtained.

製造例8:緑茶の熱水抽出工程を経て得られる精製茶多糖類の調製(その5)
緑茶熱水抽出物(ポリフェノンG、東京フードテクノ(株)製)1.5kgに2Lの70%エタノールを加えてよく攪拌した。不溶物を遠心分離して回収し、この不溶物に2Lの70%エタノールを加えて十分に攪拌後、遠心分離にて不溶物を集めた。この操作をさらに2回繰り返し、不溶物として粗茶多糖類約300gを得た。
この粗茶多糖類300gに5Lの水を加えてよく攪拌して懸濁液とし、この懸濁液を分画分子量200万の限外濾過膜(セルロースエステル膜、スペクトラム社製)を用いて分子量200万以上の成分と分子量200万未満の成分に分画した。得られた各成分を濃縮し凍結乾燥して、分子量200万以上の茶多糖類画分70gと分子量200万未満の茶多糖類画分171gを得た。
Production Example 8: Preparation of purified tea polysaccharide obtained through the hot water extraction step of green tea (part 5)
2 L of 70% ethanol was added to 1.5 kg of green tea hot water extract (Polyphenon G, manufactured by Tokyo Food Techno Co., Ltd.) and stirred well. Insoluble matters were collected by centrifugation, 2 L of 70% ethanol was added to the insoluble matters, and after sufficient stirring, the insoluble matters were collected by centrifugation. This operation was further repeated twice to obtain about 300 g of a crude tea polysaccharide as an insoluble material.
5 L of water is added to 300 g of this crude tea polysaccharide and stirred well to form a suspension. This suspension is subjected to a molecular weight of 200 using an ultrafiltration membrane (cellulose ester membrane, manufactured by Spectrum) having a molecular weight cut off of 2 million. It was fractionated into more than 10,000 components and less than 2 million components. Each component obtained was concentrated and freeze-dried to obtain 70 g of a tea polysaccharide fraction having a molecular weight of 2 million or more and 171 g of a tea polysaccharide fraction having a molecular weight of less than 2 million.

試験例1:緑茶の熱水抽出工程を経て得られる茶多糖類による排便促進作用試験(その1)
製造例1に記載の粗茶多糖類による糞の排泄促進効果を以下の試験方法に従って調べた。
(試験方法)
4週令の雄性SD系ラットを3日間固形飼料で予備飼育した後、平均体重が均等になるように群分けし、各々の群に表1に示す組成の飼料を10日間摂取させた。試験群には製造例1に記載の粗茶多糖類を添加し、コントロール群には粗茶多糖類の代わりにシュクロースを添加した。この間、飼料および水は自由に摂取させた。各々の群について、全個体の10日間の飼育期間中の糞を採取して全糞重量(乾燥重量)を測定し、これを個体数で割って1個体の10日あたりの糞重量を算出し、この糞重量を日数で割って、1個体の1日あたりの糞重量を算出した。算出結果について表2に示す。なお、飼育室温は23℃で明期8:00〜20:00、暗期20:00〜8:00とした。
Test Example 1: Defecation promoting action test by tea polysaccharide obtained through hot water extraction process of green tea (Part 1)
The fecal excretion promoting effect of the crude tea polysaccharide described in Production Example 1 was examined according to the following test method.
(Test method)
Four-week-old male SD rats were preliminarily raised on a solid diet for 3 days, then divided into groups so that the average body weight was equal, and each group was fed a diet having the composition shown in Table 1 for 10 days. The crude tea polysaccharide described in Production Example 1 was added to the test group, and sucrose was added to the control group instead of the crude tea polysaccharide. During this time, food and water were freely consumed. For each group, the feces during the 10-day breeding period of all the individuals were collected, the total fecal weight (dry weight) was measured, and this was divided by the number of individuals to calculate the fecal weight per 10 days of one individual. The fecal weight per day was calculated by dividing the fecal weight by the number of days. The calculation results are shown in Table 2. The breeding room temperature was 23 ° C. with a light period of 8:00 to 20:00 and a dark period of 20:00 to 8:00.

Figure 0004499406
Figure 0004499406

Figure 0004499406
Figure 0004499406

(試験結果)
表2から明らかなように、粗茶多糖類を摂取させた試験群では、糞重量がコントロール群に比べ有意に増加した。これより、粗茶多糖類の摂取により排便が顕著に促進され、優れた腸内機能改善効果を発揮した。
(Test results)
As is clear from Table 2, the fecal weight significantly increased in the test group ingested with the crude tea polysaccharide as compared with the control group. From this, the ingestion of the crude tea polysaccharide significantly promoted defecation and exhibited an excellent intestinal function improving effect.

試験例2:緑茶の熱水抽出工程を経て得られる茶多糖類による排便促進作用試験(その2)
製造例2に記載の分子量40万以上の茶多糖類と分子量40万未満の茶多糖類による糞の排泄促進効果を以下の試験方法に従って調べた。
(試験方法)
4週令の雄性SD系ラットを3日間固形飼料で予備飼育した後、平均体重が均等になるように群分けし、各々の群に表3に示す組成の飼料を10日間摂取させた。試験群1には製造例2に記載の分子量40万未満の茶多糖類を、試験群2には製造例2に記載の分子量40万以上の茶多糖類を添加し、コントロール群には茶多糖類の代わりにシュクロースを添加した。この間、飼料および水は自由に摂取させた。各々の群について、全個体の10日間の飼育期間中の糞を採取して全糞重量(乾燥重量)を測定し、これを個体数で割って1個体の10日あたりの糞重量を算出し、この糞重量を日数で割って、1個体の1日あたりの糞重量を算出した。算出結果について表4に示す。なお、飼育室温は23℃で明期8:00〜20:00、暗期20:00〜8:00とした。
Test Example 2: Defecation promoting action test by tea polysaccharide obtained through hot water extraction process of green tea (part 2)
The fecal excretion promoting effect of the tea polysaccharide having a molecular weight of 400,000 or more and the tea polysaccharide having a molecular weight of less than 400,000 described in Production Example 2 was examined according to the following test method.
(Test method)
Four-week-old male SD rats were preliminarily raised on a solid diet for 3 days, and then grouped so that the average body weight was equal, and each group was fed a diet having the composition shown in Table 3 for 10 days. Test group 1 contains tea polysaccharides with a molecular weight of less than 400,000 as described in Production Example 2, test group 2 with tea polysaccharides with a molecular weight of 400,000 or more as described in Production Example 2, and control group with tea Sucrose was added instead of sugars. During this time, food and water were freely consumed. For each group, the feces during the 10-day breeding period of all the individuals were collected, the total fecal weight (dry weight) was measured, and this was divided by the number of individuals to calculate the fecal weight per 10 days of one individual. The fecal weight per day was calculated by dividing the fecal weight by the number of days. Table 4 shows the calculation results. The breeding room temperature was 23 ° C. with a light period of 8:00 to 20:00 and a dark period of 20:00 to 8:00.

Figure 0004499406
Figure 0004499406

Figure 0004499406
Figure 0004499406

(試験結果)
表4から明らかなように、分子量40万未満の茶多糖類を摂取させた試験群1および分子量40万以上の茶多糖類を摂取させた試験群2のどちらも、糞重量がコントロール群に比べ有意に増加したが、中でも分子量40万以上の茶多糖類を摂取させた試験群2において、とりわけ大きく増加した。これより、茶多糖類の分子量の大きさがいずれであっても排便は十分に促進され、特に、分子量40万以上の茶多糖類を摂取すると、とりわけ優れた排便促進効果を発揮することがわかった。
また緑茶由来の茶多糖類以外にも、烏龍茶由来または紅茶由来の茶多糖類を用いて糞重量を測定したところ、茶多糖類を摂取させた試験群において、糞重量がコントロール群に比べ有意に増加した。これより、本発明において用いられる茶多糖類は、茶の種類に制限されず、排便を促進するなど、優れた腸内機能改善作用を有するものであることが確認された。
(Test results)
As is clear from Table 4, both the test group 1 ingested tea polysaccharides with a molecular weight of less than 400,000 and the test group 2 ingested tea polysaccharides with a molecular weight of 400,000 or more compared to the control group. Although it increased significantly, it increased especially especially in the test group 2 which ingested the tea polysaccharide with a molecular weight of 400,000 or more. From this, it can be seen that defecation is sufficiently promoted regardless of the molecular weight of the tea polysaccharide, and in particular, ingestion of tea polysaccharide having a molecular weight of 400,000 or more exhibits an excellent defecation promoting effect. It was.
In addition to green tea-derived tea polysaccharides, the feces weight was measured using oolong tea-derived or black tea-derived tea polysaccharides. In the test group ingested with tea polysaccharides, the fecal weight was significantly higher than the control group. Increased. From this, it was confirmed that the tea polysaccharide used in the present invention has an excellent intestinal function improving action such as promoting defecation without being limited to the type of tea.

試験例3:緑茶の熱水抽出工程を経て得られる茶多糖類による糞中の短鎖脂肪酸排泄促進作用試験
製造例2に記載の分子量40万以上の茶多糖類と分子量40万未満の茶多糖類による糞中の短鎖脂肪酸の排泄促進効果を以下の試験方法に従って調べた。
(試験方法)
4週令の雄性SD系ラットを用い、試験例2と同様の方法で飼育した。飼育終了後、糞を採取し、糞中の各短鎖脂肪酸濃度をガスクロマトグラフ(Agilent 6890 Series GC System;6890A)にて分析した。GCの分析条件を表5に示す。また糞中の短鎖脂肪酸の分析結果について、酢酸、プロピオン酸、酪酸および総短鎖脂肪酸の濃度を表6に示す。ここでいう総短鎖脂肪酸とは、酢酸、プロピオン酸、イソ酪酸、酪酸、イソ吉草酸および吉草酸を総計したものであり、吉草酸は測定量が微量であったため本試験結果から除外した。なお、飼育室温は23℃で明期8:00〜20:00、暗期20:00〜8:00とした。
Test Example 3: Test for promoting excretion of short-chain fatty acids in feces by tea polysaccharide obtained through a hot water extraction process of green tea Tea polysaccharide having a molecular weight of 400,000 or more and tea poly having a molecular weight of less than 400,000 described in Production Example 2 The effect of promoting the excretion of short-chain fatty acids in feces by saccharides was examined according to the following test method.
(Test method)
Four-week-old male SD rats were bred in the same manner as in Test Example 2. After the breeding, feces were collected, and the concentration of each short chain fatty acid in the feces was analyzed with a gas chromatograph (Agilent 6890 Series GC System; 6890A). GC analysis conditions are shown in Table 5. Table 6 shows the concentrations of acetic acid, propionic acid, butyric acid and total short chain fatty acids for the analysis results of short chain fatty acids in feces. The total short-chain fatty acid referred to here is a total of acetic acid, propionic acid, isobutyric acid, butyric acid, isovaleric acid and valeric acid, and valeric acid was excluded from the test results because the measured amount was very small. The breeding room temperature was 23 ° C. with a light period of 8:00 to 20:00 and a dark period of 20:00 to 8:00.

Figure 0004499406
Figure 0004499406

Figure 0004499406
Figure 0004499406

(試験結果)
表6から明らかなように、分子量40万未満の茶多糖類を摂取させた試験群1および分子量40万以上の茶多糖類を摂取させた試験群2のどちらも、糞中の酢酸、プロピオン酸、酪酸および総短鎖脂肪酸のすべての値がコントロール群に比べ上昇し、特に、酢酸、プロピオン酸および総短鎖脂肪酸においては、有意差がみとめられた。これより、茶多糖類の分子量の大きさがいずれであっても、糞中の短鎖脂肪酸濃度を上昇し、優れた腸内機能改善作用を発揮した。短鎖脂肪酸が腸内で増えると、腸内内容物の消化通過時間が短縮され(Oufir, L.E., Flourie, B., Des Varannes, S.B., Barry, J.L., Cloarec, D., Bornet, F., Galmiche, J.P., Gut, vol.38, p.870, 1996)、この消化通過時間の短縮が排便量の増加につながることが報告されている(Burkitt, D., Walker, A.R.P., Painter, N.S., J. Am. Med. Assoc., vol.229, p.1069, 1974)。このことからも明らかなように、本発明において用いられる茶多糖類は、その一部が腸内細菌により資化されて短鎖脂肪酸を産生することで、排便を顕著に促進させる作用を有し、便秘改善剤として期待することができることがわかった。
(Test results)
As is clear from Table 6, both test group 1 ingested tea polysaccharides with a molecular weight of less than 400,000 and test group 2 ingested tea polysaccharides with a molecular weight of 400,000 or more were acetic acid and propionic acid in feces. In addition, all values of butyric acid and total short-chain fatty acids increased compared to the control group, and in particular, significant differences were observed in acetic acid, propionic acid and total short-chain fatty acids. Thus, regardless of the molecular weight of the tea polysaccharide, the concentration of short-chain fatty acids in the feces was increased, and an excellent intestinal function improving effect was exhibited. Increasing short chain fatty acids in the intestine shortens the digestion transit time of the intestinal contents (Oufir, LE, Flourie, B., Des Varannes, SB, Barry, JL, Cloarec, D., Bornet, F., Galmiche, JP, Gut, vol.38, p.870, 1996), it has been reported that shortening the digestion transit time leads to an increase in the amount of defecation (Burkitt, D., Walker, ARP, Painter, NS, J. Am. Med. Assoc., Vol. 229, p. 1069, 1974). As is clear from this, the tea polysaccharide used in the present invention has the effect of remarkably promoting defecation by producing a short chain fatty acid partly assimilated by intestinal bacteria. It was found that it can be expected as a constipation improving agent.

以下に、本発明における腸内機能改善剤を口腔適用対象物へ配合させた処方例を示す。本発明の腸内機能改善剤を含有する飲食品は、飲食品本来の味・香りを損なうことなく、美味しく摂取できるものであった。   Below, the formulation example which mix | blended the intestinal function improving agent in this invention with the oral-applicable object is shown. The food / beverage products containing the intestinal function improving agent of the present invention can be ingested deliciously without impairing the original taste / fragrance of the food / beverage products.

処方例1:腸内機能改善剤を含有する緑茶飲料
水900mLを60℃まで加熱し、これに緑茶(ゴールド)30gを加え6分間抽出した。これを30メッシュのストレーナーで茶殻を除去し、30℃以下まで冷却した後、濾紙濾過(工業用濾紙No.26:ADVANTEC社製、捕集粒子径=3μm)により清澄化を行い、抽出液760mLを得た。この緑茶抽出液を飲用濃度(カテキン濃度60mg%)となるようにイオン交換水で稀釈し、L−アスコルビン酸を0.03重量%となるように添加した後、重曹でpH6.1〜6.3の範囲に調整し、調合液とした。この調合液に製造例1で得られた緑茶由来の茶多糖類を5重量%添加してよく攪拌した。これらを80℃以上の温度条件下でホットパック充填を行い、その後、レトルト殺菌にて、121℃、10分間(F0=10以上)の殺菌を行った。これらを室温に冷却後、腸内機能改善剤を含有する緑茶飲料を得た。
Formulation Example 1: Green tea beverage containing an intestinal function improving agent 900 mL of water was heated to 60 ° C., and 30 g of green tea (gold) was added thereto and extracted for 6 minutes. After removing the tea husk with a 30-mesh strainer and cooling to 30 ° C. or lower, it is clarified by filter paper filtration (industrial filter paper No. 26: ADVANTEC, collected particle size = 3 μm), and 760 mL of extract solution Got. This green tea extract is diluted with ion-exchanged water to a drinking concentration (catechin concentration 60 mg%), L-ascorbic acid is added to 0.03% by weight, and then pH 6.1 to 6. It adjusted to the range of 3 and was set as the preparation liquid. To this blended solution, 5% by weight of the green tea-derived tea polysaccharide obtained in Production Example 1 was added and stirred well. These were hot-pack filled under a temperature condition of 80 ° C. or higher, and then sterilized at 121 ° C. for 10 minutes (F 0 = 10 or higher) by retort sterilization. After cooling these to room temperature, a green tea beverage containing an intestinal function improving agent was obtained.

処方例2:腸内機能改善剤を含有する烏龍茶飲料
水900mLを80℃まで加熱し、これに烏龍茶(ウーロンG)30gを加え6分間抽出した。処方例1と同様にして茶殻の除去、冷却、清澄化を行い、烏龍茶抽出液810mLを得た。この烏龍茶抽出液を飲用濃度(カテキン濃度50mg%)となるようにイオン交換水で稀釈し、L−アスコルビン酸を0.03重量%となるように添加した後、重曹でpH6.1〜6.3の範囲に調整し、調合液とした。この調合液に製造例5で得られた分子量40万以上の烏龍茶由来の茶多糖類を5重量%添加してよく攪拌した。これらを80℃以上の温度条件下でホットパック充填を行い、その後、レトルト殺菌にて、121℃、10分間(F0=10以上)の殺菌を行った。これらを室温に冷却後、腸内機能改善剤を含有する烏龍茶飲料を得た。
Formulation Example 2: Oolong tea beverage containing an intestinal function improving agent 900 mL of water was heated to 80 ° C., and 30 g of Oolong tea (Oolong G) was added thereto and extracted for 6 minutes. The tea shell was removed, cooled and clarified in the same manner as in Formulation Example 1 to obtain 810 mL of oolong tea extract. This oolong tea extract is diluted with ion-exchanged water so as to have a drinking concentration (catechin concentration of 50 mg%), L-ascorbic acid is added to 0.03% by weight, and then pH 6.1-6. It adjusted to the range of 3 and was set as the preparation liquid. To this blended solution, 5% by weight of the tea polysaccharide derived from Oolong tea with a molecular weight of 400,000 or more obtained in Production Example 5 was added and stirred well. These were hot-pack filled under a temperature condition of 80 ° C. or higher, and then sterilized at 121 ° C. for 10 minutes (F 0 = 10 or higher) by retort sterilization. After these were cooled to room temperature, Oolong tea drink containing an intestinal function improving agent was obtained.

処方例3:腸内機能改善剤を含有する紅茶飲料
処方例2における烏龍茶(ウーロンG)を紅茶(ヌワヤレモンティー)に変更した以外は処方例2と同様の方法で調製し、腸内機能改善剤を含有する紅茶飲料を得た。
Formulation Example 3: Black Tea Beverage Containing Intestinal Function Improvement Agent Prepared in the same manner as Formulation Example 2 except that Oolong Tea (Oolong G) in Formulation Example 2 was changed to black tea (Nuwaya Lemon Tea) to improve intestinal function A tea beverage containing the agent was obtained.

処方例4:腸内機能改善剤を含有する麦茶飲料
水800mLを90℃まで加熱し、これに麦茶原料大麦40gを加え30分間抽出した。これを30メッシュのストレーナーで茶殻を除去し、30℃以下まで冷却した後、濾紙濾過(工業用濾紙No.2:ADVANTEC社製)により清澄化を行い、抽出液720mLを得た。この麦茶抽出液を飲用濃度(Brix 0.4゜)となるようにイオン交換水で稀釈し、L−アスコルビン酸を0.03重量%となるように添加した後、重曹でpH6.0の範囲に調整し、調合液とした。この調合液に製造例6で得られた分子量40万以上の紅茶由来の茶多糖類を5重量%添加してよく攪拌した。これらを80℃以上の温度条件下でホットパック充填を行い、その後、レトルト殺菌にて、121℃、20分間の殺菌を行った。これらを室温に冷却後、腸内機能改善剤を含有する麦茶飲料を得た。
Formulation Example 4: Barley tea beverage containing an intestinal function improving agent 800 mL of water was heated to 90 ° C., and 40 g of barley tea raw barley was added thereto and extracted for 30 minutes. After removing the tea husk with a 30 mesh strainer and cooling to 30 ° C. or lower, clarification was performed by filter paper filtration (industrial filter paper No. 2: manufactured by ADVANTEC) to obtain 720 mL of an extract. This barley tea extract is diluted with ion-exchanged water so as to have a drinking concentration (Brix 0.4 °), L-ascorbic acid is added to 0.03% by weight, and the pH is 6.0 with sodium bicarbonate. To prepare a preparation liquid. To this blended solution, 5% by weight of the tea-derived tea polysaccharide having a molecular weight of 400,000 or more obtained in Production Example 6 was added and stirred well. These were hot-packed under a temperature condition of 80 ° C. or higher, and then sterilized at 121 ° C. for 20 minutes by retort sterilization. After cooling them to room temperature, a barley tea beverage containing an intestinal function improving agent was obtained.

処方例5:腸内機能改善剤を含有する混合茶飲料
水900mLを90℃まで加熱し、これに混合茶(配合比率:烏龍茶65%、紅茶20%、ジャスミン5%、陳皮4%、ハイビスカス4%およびバナバ2%)30gを加え10分間抽出した。これを30メッシュのストレーナーで茶殻を除去し、30℃以下まで冷却した後、濾紙濾過(工業用濾紙No.2:ADVANTEC社製)により清澄化を行い、抽出液820mLを得た。この混合茶抽出液を飲用濃度(Brix 0.2゜)となるようにイオン交換水で稀釈し、L−アスコルビン酸を0.03重量%となるように添加した後、重曹でpH6.0の範囲に調整し、調合液とした。この調合液に製造例2で得られた分子量40万以上の緑茶由来の茶多糖類を5重量%添加してよく攪拌した。これらを80℃以上の温度条件下でホットパック充填を行い、その後、レトルト殺菌にて、121℃、20分間の殺菌を行った。これらを室温に冷却後、腸内機能改善剤を含有する混合茶飲料を得た。
Formulation Example 5: Mixed tea beverage containing intestinal function improving agent 900 mL of water is heated to 90 ° C., and mixed tea (mixing ratio: 65% oolong tea, 20% black tea, 5% jasmine, 4% crust, hibiscus 4 % And banaba 2%) was added and extracted for 10 minutes. After removing the tea husk with a 30-mesh strainer and cooling to 30 ° C. or lower, clarification was performed by filter paper filtration (industrial filter paper No. 2: manufactured by ADVANTEC) to obtain 820 mL of an extract. This mixed tea extract is diluted with ion-exchanged water to a drinking concentration (Brix 0.2 °), L-ascorbic acid is added to 0.03% by weight, and then pH 6.0 with sodium bicarbonate is added. It adjusted to the range and it was set as the preparation liquid. To this blended liquid, 5% by weight of green tea-derived tea polysaccharide having a molecular weight of 400,000 or more obtained in Production Example 2 was added and stirred well. These were hot-packed under a temperature condition of 80 ° C. or higher, and then sterilized at 121 ° C. for 20 minutes by retort sterilization. After cooling these to room temperature, a mixed tea beverage containing an intestinal function improving agent was obtained.

処方例6:腸内機能改善剤を含有するオレンジ50%果汁飲料
6倍濃縮オレンジ果汁 84g
果糖ブドウ糖液糖 9.7g
クエン酸 0.06g
L−アスコルビン酸 0.022g
製造例5で得られた茶多糖類 5g
香料 適量
上記記載の成分をイオン交換水に溶解し、全量を1000mLとした。これを容器に充填し、65℃で10分間加熱殺菌して、製造例5で得られた分子量40万以上の烏龍茶由来の茶多糖類を含有するオレンジ50%果汁飲料を得た。
Formulation Example 6: Orange 50% juice drink containing intestinal function improver 6 times concentrated orange juice 84g
Fructose glucose liquid sugar 9.7g
Citric acid 0.06g
L-ascorbic acid 0.022g
5 g tea polysaccharide obtained in Production Example 5
Fragrance appropriate amount The above-described components were dissolved in ion-exchanged water to make a total amount of 1000 mL. This was filled in a container and sterilized by heating at 65 ° C. for 10 minutes to obtain an orange 50% fruit juice drink containing tea polysaccharides derived from Oolong tea with a molecular weight of 400,000 or more obtained in Production Example 5.

処方例7:腸内機能改善剤を含有するオレンジ100%果汁飲料
1/6濃縮オレンジ果汁 168g
製造例6で得られた茶多糖類 10g
香料 適量
上記記載の成分をイオン交換水に溶解し、全量を1000mLとした。これを容器に充填し、65℃で10分間加熱殺菌して、製造例6で得られた分子量40万以上の紅茶由来の茶多糖類を含有するオレンジ100%果汁飲料を得た。
Formulation Example 7: Orange 100% fruit juice drink containing intestinal function improving agent 1/6 concentrated orange fruit juice 168 g
10 g tea polysaccharide obtained in Production Example 6
Fragrance appropriate amount The above-described components were dissolved in ion-exchanged water to make a total amount of 1000 mL. This was filled in a container and sterilized by heating at 65 ° C. for 10 minutes to obtain a 100% orange juice drink containing tea-derived tea polysaccharides having a molecular weight of 400,000 or more obtained in Production Example 6.

処方例8:腸内機能改善剤を含有するモモ50%果汁飲料
1/4濃縮モモ果汁 131g
果糖ブドウ糖液糖 9.7g
クエン酸 0.06g
L−アスコルビン酸 0.022g
製造例2で得られた茶多糖類 5g
香料 適量
上記記載の成分をイオン交換水に溶解し、全量を1000mLとした。これを容器に充填し、65℃で10分間加熱殺菌して、製造例2で得られた分子量40万以上の緑茶由来の茶多糖類を含有するモモ50%果汁飲料を得た。
Formulation Example 8: Peach 50% fruit juice drink containing intestinal function improving agent 1/4 concentrated peach juice 131g
Fructose glucose liquid sugar 9.7g
Citric acid 0.06g
L-ascorbic acid 0.022g
5 g tea polysaccharide obtained in Production Example 2
Fragrance appropriate amount The above-described components were dissolved in ion-exchanged water to make a total amount of 1000 mL. This was filled in a container and sterilized by heating at 65 ° C. for 10 minutes to obtain a peach 50% fruit juice drink containing tea polysaccharides derived from green tea having a molecular weight of 400,000 or more obtained in Production Example 2.

処方例9:腸内機能改善剤を含有するグレープフルーツジュース
市販のグレープフルーツジュース(サンキスト グレープフルーツジュース濃縮還元100%:サンキスト社の商品名)に本発明の製造例5で得られた分子量40万以上の烏龍茶由来の茶多糖類を3重量%添加し、腸内機能改善剤を含有するグレープフルーツジュースを調製した。
Formulation Example 9: Grapefruit juice containing an intestinal function improving agent Commercially available grapefruit juice (Sanquist grapefruit juice concentrated and reduced 100%: trade name of Sanquist) Oolong tea with a molecular weight of 400,000 or more obtained in Production Example 5 of the present invention Grapefruit juice containing an intestinal function improving agent was prepared by adding 3% by weight of the derived tea polysaccharide.

処方例10:腸内機能改善剤を含有する果肉入りグレープフルーツジュース
市販の果肉入りグレープフルーツジュース(ゴクリ:サントリー社の商品名)に本発明の製造例6で得られた分子量40万以上の紅茶由来の茶多糖類を3重量%添加し、腸内機能改善剤を含有する果肉入りグレープフルーツジュースを調製した。
Formulation Example 10: Grapefruit juice containing pulp containing an intestinal function improving agent A commercially available grapefruit juice containing pulp (Gokuri: trade name of Suntory Ltd.) derived from black tea having a molecular weight of 400,000 or more obtained in Production Example 6 of the present invention Grapefruit juice containing pulp containing 3% by weight of tea polysaccharide and containing an intestinal function improving agent was prepared.

処方例11:腸内機能改善剤を含有する野菜ジュース
市販の野菜ジュース(カゴメ野菜ジュース:カゴメ社の商品名)に本発明の製造例2で得られた分子量40万以上の緑茶由来の茶多糖類を5重量%添加し、腸内機能改善剤を含有する野菜ジュースを調製した。
Formulation Example 11: Vegetable juice containing an intestinal function improving agent Commercially available vegetable juice (Kagome vegetable juice: trade name of Kagome Co., Ltd.), obtained from green tea having a molecular weight of 400,000 or more obtained in Production Example 2 of the present invention 5% by weight of saccharide was added to prepare a vegetable juice containing an intestinal function improving agent.

処方例12:腸内機能改善剤を含有するコーヒー飲料
市販のコーヒー飲料(ブラックボトル無糖:ダイドードリンコ社の商品名)に本発明の製造例5で得られた分子量40万以上の烏龍茶由来の茶多糖類を1重量%添加し、腸内機能改善剤を含有するコーヒー飲料を調製した。
Formulation example 12: Coffee beverage containing an intestinal function improving agent Commercial coffee beverage (black bottle sugar-free: trade name of DyDo DRINCO) derived from oolong tea with a molecular weight of 400,000 or more obtained in Production Example 5 of the present invention 1% by weight of tea polysaccharide was added to prepare a coffee drink containing an intestinal function improving agent.

処方例13:腸内機能改善剤を含有するスポーツ飲料
製造例6で得られた茶多糖類 20g
ビタミンB1塩酸塩 0.45mg
ビタミンB2 0.2mg
ビタミンC 10mg
ナイアシン 0.8mg
パントテン酸Ca 0.22mg
クエン酸鉄アンモニウム 12.57mg
クエン酸 100mg
果糖 2.5g
上記記載の成分にイオン交換水を加え全量を200mLとし、製造例6で得られた分子量40万以上の紅茶由来の茶多糖類を含有するスポーツ飲料を調製した。
Formulation Example 13: Sports drink containing intestinal function improving agent Tea polysaccharide obtained in Production Example 6 20 g
Vitamin B 1 hydrochloride 0.45mg
Vitamin B 2 0.2mg
Vitamin C 10mg
Niacin 0.8mg
Pantothenic acid Ca 0.22mg
Ammonium iron citrate 12.57mg
Citric acid 100mg
Fructose 2.5g
Ion-exchanged water was added to the components described above to make a total volume of 200 mL, and a sports drink containing tea-derived tea polysaccharides having a molecular weight of 400,000 or more obtained in Production Example 6 was prepared.

処方例14:腸内機能改善剤を含有するコーラ
グラニュー糖 5g
コーラベース 0.3g
クエン酸 0.05g
製造例8で得られた茶多糖類 5g
上記記載の成分に炭酸水を加え全量を100mLとし、製造例8で得られた分子量200万以上の緑茶由来の茶多糖類を含有するコーラを調製した。
Formulation Example 14: Cola granulated sugar containing an intestinal function improving agent 5 g
Cola base 0.3g
Citric acid 0.05g
5 g tea polysaccharide obtained in Production Example 8
Carbonated water was added to the components described above to make the total amount 100 mL, and a cola containing green tea-derived tea polysaccharides having a molecular weight of 2 million or more obtained in Production Example 8 was prepared.

処方例15:腸内機能改善剤を含有するミルクシェーク
バター 1.7g
脱脂粉乳 5.5g
製造例6で得られた茶多糖類 10g
砂糖 5g
ソルビトール 4g
乳化安定剤 0.7g
上記記載の成分にイオン交換水を加え全量を100mLとし、80℃まで加温して溶解し、ホモジナイザーで乳脂肪を均質化した後、翌日まで5℃でエージングした。これをフリージング後、−40℃まで急冷し、よくミキシングして、製造例6で得られた分子量40万以上の紅茶由来の茶多糖類を含有するミルクシェークを調製した。
Formulation Example 15: 1.7 g milk shake butter containing an intestinal function improving agent
Nonfat dry milk 5.5g
10 g tea polysaccharide obtained in Production Example 6
5g sugar
Sorbitol 4g
Emulsification stabilizer 0.7g
Ion exchange water was added to the components described above to make a total volume of 100 mL, and the mixture was dissolved by heating to 80 ° C. After homogenizing the milk fat, it was aged at 5 ° C. until the next day. After freezing this, it was rapidly cooled to −40 ° C. and mixed well to prepare a milk shake containing tea-derived tea polysaccharides having a molecular weight of 400,000 or more obtained in Production Example 6.

処方例16:腸内機能改善剤を含有するドリンクヨーグルト
醸酵脱脂乳(脱脂乳を発酵させて粉砕したもの) 40g
砂糖 13g
安定剤 0.35g
香料 0.05g
製造例6で得られた茶多糖類 10g
上記記載の成分にイオン交換水を加え、全量を100gとし、混合溶解した。これをホモジナイザーで均質化して、製造例6で得られた分子量40万以上の紅茶由来の茶多糖類を含有するドリンクヨーグルトを調製した。
Formulation Example 16: Drink yogurt containing an intestinal function improver Brewed skim milk (fermented skim milk and ground) 40 g
13g sugar
Stabilizer 0.35g
Fragrance 0.05g
10 g tea polysaccharide obtained in Production Example 6
Ion exchange water was added to the components described above to make a total amount of 100 g, and mixed and dissolved. This was homogenized with a homogenizer to prepare a drink yogurt containing tea-derived tea polysaccharides having a molecular weight of 400,000 or more obtained in Production Example 6.

処方例17:腸内機能改善剤を含有する赤ワイン
市販の赤ワイン(デリカメゾン赤・ライトタイプ:サントリー社の商品名)に本発明の製造例2で得られた分子量40万以上の緑茶由来の茶多糖類を1重量%添加し、腸内機能改善剤を含有する赤ワインを調製した。
Formulation Example 17: Red wine containing an intestinal function improver A tea derived from green tea having a molecular weight of 400,000 or more obtained in Production Example 2 of the present invention in a commercially available red wine (Delica Maison Red / Light Type: trade name of Suntory) A red wine containing 1% by weight of polysaccharide and containing an intestinal function improving agent was prepared.

処方例18:腸内機能改善剤を含有するビール
市販のビール(キリンラガー:キリンビール社の商品名)に本発明の製造例5で得られた分子量40万以上の烏龍茶由来の茶多糖類を1重量%添加し、腸内機能改善剤を含有するビールを調製した。
Formulation Example 18: Beer containing an intestinal function improver A tea polysaccharide derived from Oolong tea having a molecular weight of 400,000 or more obtained in Production Example 5 of the present invention is added to a commercially available beer (Kirin Lager: trade name of Kirin Beer). A beer containing 1% by weight and containing an intestinal function improving agent was prepared.

処方例19:腸内機能改善剤を含有する豆乳飲料
大豆粉水溶液 500g
砂糖 90g
5倍濃縮モモ果汁 20g
クエン酸 3g
ペクチン 3g
ミルクフレーバー 0.5g
ピーチフレーバー 1g
製造例6で得られた茶多糖類 10g
上記記載の成分を混合し、イオン交換水を加え、全量を1000mLとした。この混合液を92℃で1〜3秒間殺菌後、87℃で容器に充填することによって、製造例6で得られた分子量40万以上の紅茶由来の茶多糖類を含有する豆乳飲料を調製した。
Formulation Example 19: Soymilk drink containing intestinal function improving agent Soybean flour aqueous solution 500 g
90g sugar
5 times concentrated peach juice 20g
Citric acid 3g
Pectin 3g
Milk flavor 0.5g
1g peach flavor
10 g tea polysaccharide obtained in Production Example 6
The components described above were mixed, and ion-exchanged water was added to make a total volume of 1000 mL. The mixture was sterilized at 92 ° C. for 1 to 3 seconds, and then filled into a container at 87 ° C. to prepare a soy milk beverage containing tea-derived tea polysaccharides having a molecular weight of 400,000 or more obtained in Production Example 6. .

処方例20:腸内機能改善剤を含有するスープ
コーンスターチ 30g
製造例2で得られた茶多糖類 5g
砂糖 5g
食塩 5g
脱脂粉乳 30g
肉エキスパウダー 1g
HAPパウダー 4g
グルタミン酸ソーダ 5g
ホワイトペッパー 0.2g
セロリパウダー 0.01g
オニオンエキスパウダー 5g
マーガリン 5g
乾燥ニンジン 5g
乾燥パセリ 0.3g
上記記載の成分をインスタントスープ処方で粉末混合し、この混合物21.5gに200mLの水を加え、よく混ぜながら3〜5分加熱し、製造例2で得られた分子量40万以上の緑茶由来の茶多糖類を含有する粉末ポタージュスープを調製した。
Formulation Example 20: 30 g of soup corn starch containing an intestinal function improving agent
5 g tea polysaccharide obtained in Production Example 2
5g sugar
5g salt
Non-fat dry milk 30g
1g meat extract powder
4g of HAP powder
5g sodium glutamate
0.2g white pepper
Celery powder 0.01g
Onion extract powder 5g
Margarine 5g
5g dried carrot
0.3g dried parsley
The ingredients described above are powder-mixed in an instant soup formulation, 200 mL of water is added to 21.5 g of this mixture, heated for 3 to 5 minutes with good mixing, and derived from green tea with a molecular weight of 400,000 or more obtained in Production Example 2. A powder potage soup containing tea polysaccharides was prepared.

処方例21:腸内機能改善剤を含有するビーフシチュー
牛肉 110g
ジャガイモ(6切れ) 60g
ニンジン(6切れ) 50g
ドミグラスソース 215g
製造例5で得られた茶多糖類 5g
4号缶に上記記載の材料を添加し、よく混合した。これを115℃で90分間レトルト殺菌し、製造例5で得られた分子量40万以上の烏龍茶由来の茶多糖類を含有するビーフシチューを調製した。
Formulation Example 21: Beef stew beef 110 g containing an intestinal function improving agent
Potato (6 slices) 60g
Carrot (6 slices) 50g
215g domiglas sauce
5 g tea polysaccharide obtained in Production Example 5
The above-mentioned materials were added to No. 4 can and mixed well. This was sterilized by retort at 115 ° C. for 90 minutes to prepare a beef stew containing tea polysaccharides derived from Oolong tea with a molecular weight of 400,000 or more obtained in Production Example 5.

処方例22:腸内機能改善剤を含有するレトルトカレー
バラ肉 12.4g
塩 0.5g
バター 5.2g
ジャガイモ 8.4g
タマネギ 12.4g
ニンジン 2.5g
小麦粉 3.6g
カレー粉 0.5g
香辛料 0.5g
製造例5で得られた茶多糖類 5g
バラ肉と野菜類を別々にフライパンで炒めて鍋にうつした。粉類を炒めてブラウンルーを作り、全体を鍋で煮詰めて、製造例5で得られた分子量40万以上の烏龍茶由来の茶多糖類を含有するレトルトカレーを調製した。
Formulation Example 22: Retort curry containing intestinal function improving agent
0.5g salt
5.2g butter
8.4g potato
Onion 12.4g
Carrot 2.5g
3.6g flour
Curry powder 0.5g
Spice 0.5g
5 g tea polysaccharide obtained in Production Example 5
Rose meat and vegetables were fried separately in a frying pan and placed in a pan. The retort curry containing tea polysaccharides derived from Oolong tea with a molecular weight of 400,000 or more obtained in Production Example 5 was prepared by frying the powder to make brown roux and simmering the whole in a pan.

処方例23:腸内機能改善剤を含有するノンオイルドレッシング
食酢 30.8g
砂糖 4g
食塩 0.5g
薄口醤油 8.4g
だし汁 26.3g
粉アメ 20g
製造例6で得られた茶多糖類 10g
液体原料を混合後、粉末原料を溶解させて、製造例6で得られた分子量40万以上の紅茶由来の茶多糖類を含有するノンオイルドレッシングを調製した。
Formulation Example 23: Non-oil dressing containing intestinal function improving agent Vinegar 30.8 g
4g sugar
Salt 0.5g
8.4g thin soy sauce
Dashi soup 26.3g
20g powdered candy
10 g tea polysaccharide obtained in Production Example 6
After mixing the liquid raw material, the powder raw material was dissolved to prepare a non-oil dressing containing tea-derived tea polysaccharides having a molecular weight of 400,000 or more obtained in Production Example 6.

処方例24:腸内機能改善剤を含有する麺つゆ(2倍濃縮タイプ)
醤油 70mL
砂糖 20g
みりん 5mL
鰹節煮出し液 9g
核酸系調味料 3g
食塩 2g
製造例8で得られた茶多糖類 5g
カラメル 適量
上記記載の成分をイオン交換水に溶解し、全量を1000mLとし、製造例8で得られた分子量200万以上の緑茶由来の茶多糖類を含有する2倍濃縮の麺つゆを調製した。
Formulation Example 24: Noodle soup containing an intestinal function improving agent (double concentration type)
70mL soy sauce
20g sugar
Mirin 5mL
Boiled bonito broth 9g
Nucleic acid seasoning 3g
2g of salt
5 g tea polysaccharide obtained in Production Example 8
Caramel appropriate amount The above-described components were dissolved in ion-exchanged water to make a total amount of 1000 mL, and a double-concentrated noodle soup containing tea polysaccharides derived from green tea having a molecular weight of 2 million or more obtained in Production Example 8 was prepared.

処方例25:腸内機能改善剤を含有する焼肉のたれ
醤油 900mL
味噌 500g
砂糖 350g
玉ねぎペースト 100g
リンゴペースト 200g
ごま油 60g
にんにくペースト 250g
白ごまペースト 20g
製造例2で得られた茶多糖類 50g
上記記載の成分をイオン交換水に溶解し、全量を2000mLとし、製造例2で得られた分子量40万以上の緑茶由来の茶多糖類を含有する焼肉のたれを調製した。
Formulation Example 25: Yakiniku sauce containing intestinal function improving agent Soy sauce 900 mL
500g miso
350g sugar
Onion paste 100g
200g apple paste
60g sesame oil
250g garlic paste
20g white sesame paste
50 g of tea polysaccharide obtained in Production Example 2
The ingredients described above were dissolved in ion-exchanged water to make a total amount of 2000 mL, and a yakiniku sauce containing green tea-derived tea polysaccharides having a molecular weight of 400,000 or more obtained in Production Example 2 was prepared.

処方例26:腸内機能改善剤を含有するマヨネーズ
卵黄 卵1個分
酢 小さじ1杯
塩 適量
サラダ油 120mL
砂糖 適量
製造例3で得られた茶多糖類 5g
上記記載の成分を常法に従ってゆっくりと加えながら混合し、製造例3で得られた緑茶由来の不溶性茶多糖類を含有するマヨネーズを調製した。
Formulation Example 26: Mayonnaise containing intestinal function improver Egg yolk One egg Vinegar 1 teaspoon Salt Suitable amount Salad oil 120mL
Appropriate amount of sugar 5 g of tea polysaccharide obtained in Production Example 3
The ingredients described above were mixed while being slowly added according to a conventional method to prepare mayonnaise containing insoluble tea polysaccharide derived from green tea obtained in Production Example 3.

処方例27:腸内機能改善剤を含有するハードヨーグルト
脱脂乳 90.9g
砂糖 5g
製造例3で得られた茶多糖類 5g
ステビオサイド 0.05g
香料 少量
硬化剤 少量
脱脂乳に硬化剤を添加後、スターターを3%接種して酸度が0.7%になったところで冷蔵した。他の原料を攪拌混合し、再度冷蔵して、製造例3で得られた緑茶由来の不溶性茶多糖類を含有するハードヨーグルトを調製した。
Formulation Example 27: Hard yogurt containing intestinal function improving agent Nonfat milk 90.9 g
5g sugar
5 g tea polysaccharide obtained in Production Example 3
Stevioside 0.05g
Fragrance Small amount Curing agent Small amount After adding a curing agent to skim milk, 3% starter was inoculated and refrigerated when the acidity reached 0.7%. Other raw materials were stirred and mixed, and refrigerated again to prepare hard yogurt containing insoluble tea polysaccharides derived from green tea obtained in Production Example 3.

処方例28:腸内機能改善剤を含有するアイスクリーム
バター 7.5g
脱脂粉乳 5g
砂糖 10g
製造例3で得られた茶多糖類 5g
乳化安定剤 0.7g
粉あめ(DE 8) 7g
上記記載の成分にイオン交換水を加え、全量を100gとし、よく混合した。これを70℃まで加熱してホモミキサーで攪拌後、ホモジナイザーで均質化した。冷蔵庫で1日エージングし、フリージング後に−40℃に急冷して、製造例3で得られた緑茶由来の不溶性茶多糖類を含有するアイスクリームを調製した。
Formulation Example 28: 7.5 g of ice cream butter containing an intestinal function improving agent
Nonfat dry milk 5g
10g sugar
5 g tea polysaccharide obtained in Production Example 3
Emulsification stabilizer 0.7g
Flour candy (DE 8) 7g
Ion exchange water was added to the components described above to make the total amount 100 g and mixed well. This was heated to 70 ° C., stirred with a homomixer, and then homogenized with a homogenizer. The ice cream containing the insoluble tea polysaccharide derived from the green tea obtained in Production Example 3 was prepared by aging in a refrigerator for 1 day and then rapidly cooling to −40 ° C. after freezing.

処方例29:腸内機能改善剤を含有するコーヒーホワイトナー(粉末タイプ)
大豆硬化油 50g
水飴 25g
乳化剤 0.84g
クリームフレーバー 0.16g
製造例2で得られた茶多糖類 20g
乾物に対して66.6%の湯に水溶性原料を溶解し、油に乳化剤を溶解した。両者を60℃で乳化、均質化後にスプレードライして、製造例2で得られた分子量40万以上の緑茶由来の茶多糖類を含有するコーヒーホワイトナー(粉末タイプ)を調製した。
Formulation Example 29: Coffee whitener (powder type) containing an intestinal function improving agent
Soybean hardened oil 50g
25g Minamata
Emulsifier 0.84g
Cream flavor 0.16g
20 g of tea polysaccharide obtained in Production Example 2
A water-soluble raw material was dissolved in 66.6% hot water with respect to the dry matter, and an emulsifier was dissolved in oil. Both were emulsified at 60 ° C., homogenized, and spray-dried to prepare a coffee whitener (powder type) containing tea polysaccharides derived from green tea having a molecular weight of 400,000 or more obtained in Production Example 2.

処方例30:腸内機能改善剤を含有する漬物用調味液
昆布エキス 6g
鰹節エキス 4g
食塩 4g
製造例2で得られた茶多糖類 1g
上記成分をイオン交換水に溶解し、全量を100gとし、製造例2で得られた分子量40万以上の緑茶由来の茶多糖類を含有する漬物用調味液を調製した。
Formulation Example 30: Seasoning liquid for pickles containing an intestinal function improving agent Kelp extract 6 g
4g bonito extract
4g of salt
1 g of tea polysaccharide obtained in Production Example 2
The said component was melt | dissolved in ion-exchange water, the whole quantity was 100 g, and the seasoning liquid for pickles containing the tea polysaccharide derived from the green tea with a molecular weight of 400,000 or more obtained by manufacture example 2 was prepared.

処方例31:腸内機能改善剤を含有するゼリー
1/5濃縮ブドウ果汁 10g
製造例5で得られた茶多糖類 20g
砂糖 15g
ブドウ糖 20g
水飴 12g
上記成分をイオン交換水で加温しながら完全に溶解し、全量を100gとした。これをカップ容器に注ぎ、ヒートシールで蓋をして冷却し、製造例5で得られた分子量40万以上の烏龍茶由来の茶多糖類を含有するゼリーを調製した。
Formulation example 31: Jelly containing intestinal function improving agent 1/5 Concentrated grape juice 10 g
20 g of tea polysaccharide obtained in Production Example 5
15g sugar
Glucose 20g
Minamata 12g
The above components were completely dissolved while heating with ion-exchanged water to make a total amount of 100 g. This was poured into a cup container, covered with a heat seal and cooled to prepare a jelly containing Oolong tea-derived tea polysaccharide having a molecular weight of 400,000 or more obtained in Production Example 5.

処方例32:腸内機能改善剤を含有するキャンディー
砂糖 50g
水飴 100g
クエン酸 1g
香料 0.4g
着色料 0.1g
製造例6で得られた茶多糖類 50g
上記記載の成分をキャンディー処方により常法で、製造例6で得られた分子量40万以上の紅茶由来の茶多糖類を含有するキャンディー30個を調製した。
Formulation Example 32: Candy containing intestinal function improving agent Sugar 50 g
Minamata 100g
Citric acid 1g
Perfume 0.4g
Coloring agent 0.1g
50 g tea polysaccharide obtained in Production Example 6
Thirty candies containing tea-derived tea polysaccharides having a molecular weight of 400,000 or more obtained in Production Example 6 were prepared by a conventional method using the above-described components according to a candy formulation.

処方例33:腸内機能改善剤を含有するチューイングガム
酢酸ビニール樹脂 20g
可塑剤 3g
ポリイソブチレン 3g
マイクロクリスタルワックス 2g
炭酸カルシウム 2g
砂糖 40g
ブドウ糖 20g
製造例2で得られた茶多糖類 10g
アスパルテーム 0.3g
香料 1g
糖質と香料以外の原料を鍋にとり、加熱溶解してよく混合した。50℃に冷却して糖質を添加混合し、40℃で香料を添加して成型後、放冷して、製造例2で得られた分子量40万以上の緑茶由来の茶多糖類を含有するガムを調製した。
Formulation Example 33: Chewing gum containing an intestinal function improving agent Vinyl acetate resin 20 g
Plasticizer 3g
Polyisobutylene 3g
Microcrystal wax 2g
Calcium carbonate 2g
40g sugar
Glucose 20g
10 g of tea polysaccharide obtained in Production Example 2
Aspartame 0.3g
1g fragrance
Ingredients other than sugar and fragrance were placed in a pan, heated and dissolved, and mixed well. Cooled to 50 ° C., added and mixed with sugar, added fragrance at 40 ° C., molded, allowed to cool, and contains tea polysaccharide derived from green tea having a molecular weight of 400,000 or more obtained in Production Example 2 A gum was prepared.

処方例34:腸内機能改善剤を含有するスイートチョコレート
ビターチョコ 33.2g
砂糖 50g
製造例8で得られた茶多糖類 10g
アスパルテーム 0.31g
カカオバター 11.1g
上記記載の成分を40℃でよく混合し、さらに、ライカイ機で長時間練り上げて粒子を微細にした。成型後冷却して、製造例8で得られた分子量200万以上の緑茶由来の茶多糖類を含有するスイートチョコレートを調整した。
Formulation Example 34: Sweet chocolate bitter chocolate 33.2 g containing an intestinal function improving agent
50g sugar
10 g tea polysaccharide obtained in Production Example 8
Aspartame 0.31g
Cocoa butter 11.1g
The above-described components were mixed well at 40 ° C., and further kneaded for a long time with a reika machine to make the particles fine. It cooled after shaping | molding and the sweet chocolate containing the tea polysaccharide derived from the green tea with a molecular weight of 2 million or more obtained by manufacture example 8 was adjusted.

処方例35:腸内機能改善剤を含有するジャム
オレンジ果皮 250g
砂糖 100g
クエン酸 0.5g
製造例2で得られた茶多糖類 50g
上記記載の成分を常法により煮詰め、製造例2で得られた分子量40万以上の緑茶由来の茶多糖類を含有するジャムを調製した。
Formulation Example 35: Jam Orange peel containing intestinal function improving agent 250 g
100g sugar
Citric acid 0.5g
50 g of tea polysaccharide obtained in Production Example 2
The above-described components were boiled by a conventional method to prepare a jam containing tea polysaccharides derived from green tea having a molecular weight of 400,000 or more obtained in Production Example 2.

処方例36:腸内機能改善剤を含有するクッキー
薄力粉 100g
澱粉 74g
水 14g
製造例3で得られた茶多糖類 15g
ベーキングパウダー 小さじ2
塩 小さじ2
卵 1個
バター 80g
牛乳 大さじ2
上記記載のクッキー処方により常法で、製造例3で得られた緑茶由来の不溶性茶多糖類を含有するクッキー30個を調製した。
Formulation Example 36: Cookie containing intestinal function improving agent
74g starch
14g of water
15 g of tea polysaccharide obtained in Production Example 3
2 tsp baking powder
2 teaspoons of salt
1 egg butter 80g
2 tablespoons milk
Thirty cookies containing insoluble tea polysaccharides derived from green tea obtained in Production Example 3 were prepared by a conventional method using the above-described cookie formulation.

処方例37:腸内機能改善剤を含有するカスタードクリーム
上白糖 10g
ブドウ糖 5g
水飴 6.2g
製造例2で得られた茶多糖類 10g
小麦粉 3.8g
加工澱粉 7g
脱脂粉乳 1.3g
マーガリン 7.9g
卵黄(粉) 0.2g
イオン交換水 41.9g
少量の水に小麦粉、加工澱粉、卵黄(粉)を混合したものに、残りの水を80℃にして他の原料を溶解したものを、泡立て器を使用しながら添加して強火で煮て、製造例2で得られた分子量40万以上の緑茶由来の茶多糖類を含有するカスタードクリームを調製した。
Formulation Example 37: Custard cream containing intestinal function improving agent Upper white sugar 10 g
Glucose 5g
Minamata 6.2g
10 g of tea polysaccharide obtained in Production Example 2
3.8g of flour
Modified starch 7g
Nonfat dry milk 1.3g
Margarine 7.9g
Egg yolk (powder) 0.2g
Ion-exchanged water 41.9g
To a mixture of wheat flour, processed starch, egg yolk (powder) in a small amount of water, add the remaining water to 80 ° C and dissolve other ingredients, add it using a whisk and boil on high heat, A custard cream containing green tea-derived tea polysaccharides having a molecular weight of 400,000 or more obtained in Production Example 2 was prepared.

処方例38:腸内機能改善剤を含有する練りようかん
生あん 36.8g
かんてん 0.8g
水 7.2g
砂糖 40g
製造例2で得られた茶多糖類 10g
水で膨張させたかんてんに、水、砂糖、茶多糖類を加え、加熱沸騰して溶解させた。これをうらごしした後、再沸騰させ、生あんを添加し、全量が100gになるまで煮詰めた。成型、冷却し、製造例2で得られた分子量40万以上の緑茶由来の茶多糖類を含有する練りようかんを調製した。
Formulation Example 38: Kuriyokan Nangan 36.8g containing an intestinal function improving agent
Kanten 0.8g
7.2 g of water
40g sugar
10 g of tea polysaccharide obtained in Production Example 2
Water, sugar, and tea polysaccharides were added to the swelled water and dissolved by boiling under heating. After shaking this, it was boiled again, added with raw bean paste, and boiled until the total amount was 100 g. A kneaded candy containing green tea-derived tea polysaccharide having a molecular weight of 400,000 or more obtained in Production Example 2 was prepared.

処方例39:腸内機能改善剤を含有するパン
強力粉 100g
ドライイースト 3g
ショートニング 4g
脱脂粉乳 5g
食塩 2g
水 60g
製造例3で得られた茶多糖類 10g
上記成分を配合して、常法により製造例3で得られた緑茶由来の不溶性茶多糖類を含有するパンを調製した。
Formulation Example 39: Bread containing an intestinal function improving agent
3g dry yeast
Shortening 4g
Nonfat dry milk 5g
2g of salt
60g of water
10 g tea polysaccharide obtained in Production Example 3
The above ingredients were blended to prepare bread containing insoluble tea polysaccharides derived from green tea obtained in Production Example 3 by a conventional method.

処方例40:腸内機能改善剤を含有するスパゲッティー
小麦粉 100g
水 25g
製造例3で得られた茶多糖類 5g
粉類を混合し、これに水を少量ずつ加えながら均一に練りこみ、製造例3で得られた緑茶由来の不溶性茶多糖類を含有するスパゲッティーを調製した。
Formulation Example 40: Spaghetti flour containing intestinal function improving agent 100 g
25 g of water
5 g tea polysaccharide obtained in Production Example 3
Powders were mixed and kneaded uniformly while adding water little by little to prepare spaghetti containing insoluble tea polysaccharides derived from green tea obtained in Production Example 3.

処方例41:腸内機能改善剤を含有する中華麺
超強力粉 70g
馬鈴薯澱粉 30g
食塩 1g
かんすい 2g
水 48g
製造例3で得られた茶多糖類 10g
上記記載の原料を混合し、常法に従って混捏、成形、複合、熟成、圧延して麺帯を形成して麺線に切り出し、製造例3で得られた緑茶由来の不溶性茶多糖類を含有する中華麺を調製した。
Formulation Example 41: Chinese noodles containing an intestinal function improving agent Super strong powder 70 g
Potato starch 30g
1g of salt
Kansui 2g
48g of water
10 g tea polysaccharide obtained in Production Example 3
Mixing the raw materials described above, kneading, forming, compounding, aging and rolling according to conventional methods to form a noodle band, cut into noodle strings, and containing the insoluble tea polysaccharide derived from green tea obtained in Production Example 3 Chinese noodles were prepared.

処方例42:腸内機能改善剤を含有する即席中華麺
市販中華麺用粉 60g
超強力粉 40g
馬鈴薯澱粉 12g
食塩 2g
市販かんすい 0.3g
水 35g
製造例3で得られた茶多糖類 10g
上記記載の原料をミキサーに入れミキシングし、荒延、圧延、切り出しを行い、麺線を得た。この麺線を100℃で蒸煮し、150℃の油で揚げ、製造例3で得られた緑茶由来の不溶性茶多糖類を含有する即席中華麺を調製した。
Formulation Example 42: Instant Chinese noodles containing intestinal function improving agent Commercial Chinese noodle powder 60 g
Super strong powder 40g
Potato starch 12g
2g of salt
Commercial kansui 0.3g
35g of water
10 g tea polysaccharide obtained in Production Example 3
The raw materials described above were put into a mixer, mixed, rough rolled, rolled and cut out to obtain noodle strings. The noodle strings were steamed at 100 ° C. and fried in oil at 150 ° C. to prepare instant Chinese noodles containing insoluble tea polysaccharides derived from green tea obtained in Production Example 3.

処方例43:腸内機能改善剤を含有する冷凍うどん
小麦粉 100g
食塩 3g
水 30g
製造例3で得られた茶多糖類 10g
上記記載の成分をミキサーに入れミキシングし、熟成、圧延、切り出しを行い、麺線を得た。この麺線を沸騰水中に入れて約5分間茹で上げ、冷水で10℃まで冷却した。1玉分の麺線を取り出し、水切りした後、容器に厚さが均一となるようにならしながら入れて、−30℃にて急速冷凍し、製造例3で得られた緑茶由来の不溶性茶多糖類を含有する冷凍うどんを調製した。
Formulation Example 43: Frozen udon noodles containing an intestinal function improving agent 100 g
3g of salt
30 g of water
10 g tea polysaccharide obtained in Production Example 3
The components described above were put in a mixer, mixed, aged, rolled, and cut out to obtain noodle strings. The noodle strings were put in boiling water, boiled for about 5 minutes, and cooled to 10 ° C. with cold water. After taking out the noodle strings for one ball, draining them, putting them in a container with a uniform thickness, quickly freezing at −30 ° C., and insoluble tea derived from green tea obtained in Production Example 3 Frozen udon containing polysaccharides was prepared.

処方例44:腸内機能改善剤を含有する春巻き用の皮
小麦澱粉 99g
小麦粉 1g
乳化剤 3g
サラダ油 2g
酒 2g
食塩 2g
水 43g
製造例8で得られた茶多糖類 2g
上記記載の成分を攪拌混練してペースト状の生地を作り、回転ドラムに1mmの厚さに塗り付けて焼成して、できた生地を切断した12cm×12cmの正方形に成型し、製造例8で得られた分子量200万以上の緑茶由来の茶多糖類を含有する春巻きの皮を調製した。
Formulation Example 44: Spring roll skin containing intestinal function improving agent Wheat starch 99 g
1g flour
Emulsifier 3g
2g salad oil
Sake 2g
2g of salt
43g of water
2 g tea polysaccharide obtained in Production Example 8
The ingredients described above were stirred and kneaded to make a pasty dough, applied to a rotating drum to a thickness of 1 mm and baked, and the resulting dough was cut into a cut 12 cm × 12 cm square. A spring roll peel containing tea polysaccharides derived from green tea having a molecular weight of 2 million or more was prepared.

処方例45:腸内機能改善剤を含有するビーフ&ポークソーセージ
牛肉 22g
水 17.3g
食塩 1.7g
塩漬け剤 0.01g
砂糖 1g
グルタミン酸ソーダ 0.5g
スパイス 0.5g
馬糊 3g
豚肩肉 54g
製造例3で得られた茶多糖類 10g
上記記載の成分を生のまま粉砕して混合し、フィルムに充填した。塩漬として5℃で12時間放置した後、75℃で90分間ボイルしてから冷蔵し、製造例3で得られた緑茶由来の不溶性茶多糖類を含有するビーフ&ポークソーセージを調製した。
Formulation Example 45: Beef & pork sausage containing an intestinal function improving agent 22g beef
17.3g of water
Salt 1.7g
0.01g salting agent
1g sugar
Sodium glutamate 0.5g
Spice 0.5g
Horse glue 3g
Pork shoulder meat 54g
10 g tea polysaccharide obtained in Production Example 3
The above ingredients were ground and mixed as it was and filled into a film. After being left as salted at 5 ° C. for 12 hours, boiled at 75 ° C. for 90 minutes and then refrigerated, to prepare beef and pork sausage containing insoluble tea polysaccharides derived from green tea obtained in Production Example 3.

処方例46:腸内機能改善剤を含有するかまぼこ
スリミ 60g
塩 1.8g
氷 30.4g
澱粉 6g
調味料 1.8g
製造例3で得られた茶多糖類 6g
スリミと塩と少量の氷を混合し、サイレント・カッターで破断混合を5分間行った後、残りの氷と原料を追加して続けて10分間混合した。15℃で粘りが出たところで終了し、型とりをして160℃の油で4分間フライして、製造例3で得られた緑茶由来の不溶性茶多糖類を含有するかまぼこを調製した。
Formulation Example 46: Kamaboko Surimi 60g containing an intestinal function improving agent
1.8g of salt
30.4g ice
6g starch
Seasoning 1.8g
6 g tea polysaccharide obtained in Production Example 3
The surimi, salt, and a small amount of ice were mixed, and break mixing was performed with a silent cutter for 5 minutes, and then the remaining ice and raw materials were added and mixed for 10 minutes. The mixture was finished when it became sticky at 15 ° C., molded, and fried with 160 ° C. oil for 4 minutes to prepare kamaboko containing the green tea-derived insoluble tea polysaccharide obtained in Production Example 3.

処方例47:腸内機能改善剤を含有する内服液剤
製造例2で得られた茶多糖類 10g
ニンジン乾燥エキス 214mg
イカリソウ乾燥エキス 50mg
ウルソデスオキシコール酸 25mg
D−ソルビトール 50g
白糖 25g
ポリオキシエチレン硬化ヒマシ油 3g
プロピレングリコール 5mL
安息香酸ナトリウム 600mg
パラオキシ安息香酸ブチル 10mg
クエン酸塩緩衝液 適量
上記成分にイオン交換水を加え全量を300mLとし、製造例2で得られた分子量40万以上の緑茶由来の茶多糖類を含有する内服液剤を調製した。
Formulation Example 47: Oral solution containing an intestinal function improving agent Tea polysaccharide obtained in Production Example 2 10 g
Carrot dry extract 214mg
Dried licorice extract 50mg
Ursodeoxycholic acid 25mg
D-sorbitol 50g
25g white sugar
Polyoxyethylene hydrogenated castor oil 3g
Propylene glycol 5mL
Sodium benzoate 600mg
Butyl paraoxybenzoate 10mg
Citrate buffer appropriate amount Ion-exchanged water was added to the above components to make the total amount 300 mL, and an internal liquid solution containing tea polysaccharide derived from green tea having a molecular weight of 400,000 or more obtained in Production Example 2 was prepared.

本発明の腸内機能改善剤は、前記の通り、各種口腔適用対象物に添加することができる。   As described above, the intestinal function improving agent of the present invention can be added to various oral application objects.

Claims (3)

茶の水乃至熱水抽出工程を経て得られる分子量40万以上の多糖類を有効成分とすることを特徴とする腸内機能改善剤 An intestinal function improving agent comprising, as an active ingredient, a polysaccharide having a molecular weight of 400,000 or more obtained through a tea water or hot water extraction step . 有効量の請求項1記載の腸内機能改善剤を配合してなることを特徴とする腸内機能改善用医薬品。   A pharmaceutical composition for improving intestinal function, comprising an effective amount of the intestinal function improving agent according to claim 1. 有効量の請求項1記載の腸内機能改善剤を配合してなることを特徴とする腸内機能改善用医薬部外品。   A quasi drug for improving intestinal function, comprising an effective amount of the intestinal function improving agent according to claim 1.
JP2003423575A 2003-12-19 2003-12-19 Intestinal function improving agent Expired - Fee Related JP4499406B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003423575A JP4499406B2 (en) 2003-12-19 2003-12-19 Intestinal function improving agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003423575A JP4499406B2 (en) 2003-12-19 2003-12-19 Intestinal function improving agent

Publications (2)

Publication Number Publication Date
JP2005179279A JP2005179279A (en) 2005-07-07
JP4499406B2 true JP4499406B2 (en) 2010-07-07

Family

ID=34784064

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003423575A Expired - Fee Related JP4499406B2 (en) 2003-12-19 2003-12-19 Intestinal function improving agent

Country Status (1)

Country Link
JP (1) JP4499406B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5275678B2 (en) * 2007-08-07 2013-08-28 株式会社 日本薬用食品研究所 Intestinal motility enhancing and pancreatic lipase inhibitory components of tea flowers and their uses
JP5503901B2 (en) * 2009-05-20 2014-05-28 キリンホールディングス株式会社 Bitter taste inhibitor
CN104105685B (en) * 2012-02-10 2016-10-19 科学与工业研究会 Purification dissociates the no-solvent process of biological amino acid
US20230000120A1 (en) * 2019-12-09 2023-01-05 Societe Des Produits Nestle S.A. Beverage paste
JP7318997B1 (en) 2022-04-27 2023-08-01 株式会社サーフビバレッジ Packaged beverage and its manufacturing method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988008257A1 (en) * 1987-04-25 1988-11-03 Terumo Kabushiki Kaisha Food facilitating bowel movement
JP2003518937A (en) * 2000-01-07 2003-06-17 コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジー Animal feed containing simple polysaccharides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5729292A (en) * 1980-07-28 1982-02-17 Showa Sangyo Kk Preparation of polysaccharide having cholesterol reducing action
JPS63165325A (en) * 1986-12-27 1988-07-08 Snow Brand Milk Prod Co Ltd Intestine-conditioning agent
JPH0680580A (en) * 1992-09-02 1994-03-22 Itouen:Kk Plasma cholesterol depressant and its production

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988008257A1 (en) * 1987-04-25 1988-11-03 Terumo Kabushiki Kaisha Food facilitating bowel movement
JP2003518937A (en) * 2000-01-07 2003-06-17 コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジー Animal feed containing simple polysaccharides

Also Published As

Publication number Publication date
JP2005179279A (en) 2005-07-07

Similar Documents

Publication Publication Date Title
JP4076229B1 (en) Fermented black onion that is softer than raw onion and retains the original shape of raw onion, processed product thereof, and method for producing the same
CN115334906B (en) Masking agent
JP4448266B2 (en) Chillability improving agent and composition for improving cooling performance
JP5053558B2 (en) β-glucan composition, health supplement and health food
JP4503402B2 (en) Unpleasant taste reducing action and unpleasant odor reducing action
JP5013588B2 (en) Blood lipid improver
CN105495281A (en) Taste modulator and method of use thereof
JP4406780B2 (en) Method for producing anti-influenza virus agent and other drugs using active ingredient of birch moth, and method for producing health food and drink product
JP4625750B2 (en) Food and drink containing chitosan
JP4065834B2 (en) Tea polysaccharides
JP3902153B2 (en) Bitter / astringent taste inhibitor
JP4499406B2 (en) Intestinal function improving agent
JP4382465B2 (en) Mucosal immunostimulant
JP2005179277A (en) Agent for inhibiting fat from accumulating in liver
JP6753618B2 (en) Composition for suppressing increase in triglyceride in blood
JP5354520B2 (en) Novel peptide composition having kokumi imparting function
KR20090019964A (en) A anti-obesity composition comprising chia seed
JP2547573B2 (en) Beverage manufacturing method
JP2002253141A (en) Food and drink containing phosphorylated saccharide as taste quality improver
JP4028703B2 (en) Brain blood flow enhancer
JP5890732B2 (en) How to improve the flavor of food and drink
JP2020186264A (en) In-blood neutral fat increase inhibitory composition
JP2007269685A (en) Physiological function enhancing composition
JP2020127392A (en) Intestinal function-controlling medicine containing inulin
JP5013587B2 (en) Anti-obesity agent

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050804

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080617

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090303

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090420

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090616

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091006

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091204

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100105

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100219

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100406

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100415

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130423

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130423

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130423

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140423

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees